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ABSTACT 
 
Controlled biomolecule release technology represents one of the fastest advancing 
areas of science and engineering. For instance, in drug delivery area, such release system 
offers numerous advantages compared to conventional dosage drug forms including 
improved efficiency, reduced toxicity and controlled release profile. Current challenges in 
this area include biocompatiblity and biodegrability of the materials used in the system, 
controllablity and effectivity of the control mechanism, easiness of device fabraiction and 
drug loading loss as well as total cost. In this work, a simple and effective method is adopted 
to design and fabricate controlled release devices employing smart conmtrol mechanism. 
Such a technology could be further applied in pharmaceutics, biomeidical science and 
biotechnologies. 
Controlled molecule release devices in this work employ the advantage of core-shell 
structures. In the first design, core-shell microcapsules are developed capable of regulating 
the release profile of encapsulated molecules. These microcapsules uniquely contain 
embedded miniature actuators inside their liquid core. The internal actuators are made of 
stimuli-responsive smart hydrogel beads. The embedded hydrogel beads swell in response to 
external electric fields, regulating the internal pressure of the liquid core, and thus the 
diffusion rate, of the encapsulated molecules from the microcapsules. The incorporation of 
the actuators into the interior of the microcapsules provides an internal control variable to a 
conventional diffusion-based release process. The microcapsules, which behave much like 
micro-electro-mechanical systems (MEMS), are fabricated by a simple co-electrospray 
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process. This fabrication technique allows integrating the hydrogel beads, forming the 
polymer shell, and loading the releasable molecules simultaneously in one step. 
The other controlled release device is developed by embedding nanofluidic 
biomolecule reservoirs into a polymer network of a stimuli-responsive hydrogel. The 
reservoirs are made of liquid core-polymer shell nanofibers using co-electrospinning 
technique. The mechanism of controlled release is based on buckling instability of the 
polymer shell under combined axial and radial compression, caused by volume changes of 
hydrogel responding to a specific external stimulus. The device decouples releasable 
biomolecules from a hydrogel polymer matrix, avoiding chemical interactions between 
biomolecules and hydrogel polymer chains, and thus, alleviating nontrivial chemical and 
biological engineering design of hydrogel formulations. Temperature-sensitive hydrogel is 
used as a model hydrogel. 
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CHAPTER 1. INTRIDUCTION TO CONTROLLED DRUG 
RELEASE 
1.1 Introduction to Controlled Drug Release 
 
Controlled drug release technology represents one of the fastest advancing areas of 
science and engineering in which scientist and engineers are contributing to human health 
care [1]. Such release systems offer numerous advantages compared to conventional dosage 
drug forms including improved efficiency, reduced toxicity and controlled release profile. 
Conventional oral drug administration does not usually provide rate-controlled release or 
target specificity. In many cases, conventional drug delivery provides sharp increase of drug 
concentration at potentially toxic levels. Following a relatively short period at the therapeutic 
level, drug concentration eventually drops off until re-administration. The goal of developing 
novel drug release system is to revolutionize the traditional drug release format, improving 
the effectiveness of drug therapy. This improvement can take the form of increasing 
therapeutic activity compared to the intensity of side effects, reducing the number of drug 
administrations required during treatment, or eliminating the need for specialized drug 
administration.  
The idea of controlled release from polymers dates back to 1960s through the 
employment of silicone rubber and polyethylene. The lack of degradability in these systems 
implies the requirement of eventual surgical removal and therefore limits their further 
application. In the 1970s, biodegradable polymers were suggested as appropriate drug 
delivery candidate materials circumventing the requirement of post-removal. The idea of 
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polymer microcapsules as delivery systems was reported as early as the 1960s and 
degradation was incorporated by Mason et al. through the employment of a degradable 
polymer coating [2].  
Two classes of control over drug release can be realized: temporal control and 
distribution control [1]. In temporal control, drug delivery systems aim to delivery the drug 
over an extended duration or at a pre-defined specific time during treatment or 
administration. Controlled release over an extended duration is highly desired for drugs that 
are rapidly metabolized and eliminated from the body after administration. There are two 
major situations in which distribution control can be beneficial. The first is when the natural 
distribution causes drug molecules to encounter tissues and cause major side effects that 
prohibit further treatment. This situation is often the cause of chemotherapy failure when 
bone marrow cell death prevents the patient from undergoing a complete drug treatment. The 
second situation is when the natural distribution of the drug does not allow drug molecules to 
reach their molecular site of action. For instance, a drug molecule that acts on a receptor in 
the brain will not be active if it is distributed by the patient’s blood system but cannot across 
the blood-brain barrier. The advantage of sustained release is shown in Figure 1-1 in which 
the drug concentration at the site of activity within the body is compared after immediately 
release from four injections administered at six hourly intervals and after extended release 
from a controlled release system. 
A variety range of mechanisms have been employed to achieve both temporal and 
distribution controlled release of drugs using polymers. This diversity is a necessary 
consequence of different drugs imposing various restrictions on the type of delivery system 
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employed. Polymers have been employed extensively in drug release applications. One of the 
significant concerns in designing polymers for any controlled release system is the fate of the 
polymer after drug release. Therefore, polymers that are naturally excreted from the body are 
the most desirable one for many controlled release applications. Non-degradable polymers 
could be used in applications where such polymers could be recovered after drug release. 
 
Figure 1-1 Drug concentrations at site of therapeutic action after delivery as a conventional 
injection (thin line) and as a temporal controlled release system (bold line). 
 
1.2 Controlled Release Mechanism 
 
Most drug molecules need to be dissolved in the aqueous environment of the patient 
and freely diffuse within that media before they can be functional on their target acceptors or 
locations. Temporal controlled release protects drug molecules from this aqueous living 
environment for preprogrammed periods of time. This protection can involve delaying the 
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dissolution of drug molecules, inhibiting the diffusion of the drug out of the device, or 
controlling the flow of drug solutions.  
 
Figure 1-2 Examples of temporal release mechanisms 
Polymers employed to delay drug dissolution aim to slow the rate at which drug 
molecules are exposed to water from the aqueous environment surrounding the drug delivery 
system. This might be achieved by a polymer coating or matrix that dissolves at a slower rate 
than the drug. In diffusion controlled release mode, drug molecule diffusion within an 
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aqueous solution is inhibited by the insoluble polymer matrix in which drug molecules must 
travel through pathways to exit the device. The barrier to diffusion can be decreased by 
swelling of the hydrogel which creates voids in the gel structure. Such hydrogels may also 
benefit from bio-adhesive properties which allow them to reside for extended time periods. 
Polymers used for diffusion controlled release can be fabricated as either matrices in which 
drug is uniformly distributed or as a rate reservoir from the living environment as shown in 
Figure 1-2. Devices that regulate the flow of drug solution sometimes use osmotic potential 
gradients across semipermeable polymer barriers to generate pressurized chambers 
containing aqueous solutions of the drug. This pressure is relieved by the flow of the solution 
out of the delivery device. The rate of flow is controlled through a micrometer scale to a 
larger diameter pores. Many of the temporal controlled release devices utilize the diffusion 
controlled mechanisms.  
Another form of temporal control release is responsive drug delivery in which drug is 
released in a pulsatile manner only when required by the body [3]. An example for this 
application is the delivery of insulin to diabetics. Responsive drug delivery is proposed to 
revolutionize such therapy with the design of systems that release drugs in response to 
increased blood glucose levels. Generally, responsive drug delivery system contains two 
components: a sensor that detects the environmental parameter of interests that stimulates the 
drug release and a delivery device that releases drugs. The concept of responsive drug 
delivery can be used for any drug therapy in which a sensor and delivery device can be 
coupled. 
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The other controlled mechanism is distribution controlled drug release. The simplest 
method of achieving distribution control is to implant the drug delivery system directly at the 
site where drug is necessary. For most of diseases that require distribution controlled release 
of drug, a targeting mechanism should be employed that allows the delivery system to search 
the desired target. Polymers are used in two types of delivery systems for these applications, 
colloidal carriers and polymer-drug conjugates. In colloidal formulations, the polymer 
encapsulates drug within nano and microparticles. In polymer-drug conjugates, the drug is 
covalently coupled to the polymer. In these forms of distribution controlled release, the 
polymer acts as a carrier but is not responsible for targeting the delivery device. Biological 
molecules such as immuniglobulins and carbohydrates are frequently utilized as targeting 
moieties.  
1.3 Polymers Used for Controlled Drug Release 
 
Polymers are very widely used in drug delivery science. Classifications of polymer in 
controlled release applications can be difficult due to the inherent diversity of structures. 
However, it is beneficial to attempt this classification because it can highlight common 
properties within groups of polymers. In broad terms, polymers can be classified as either 
biodegradable or non-biodegradable. Biodegradable systems have attracted much of the 
recent interest and development in drug delivery systems because non-biodegradable systems 
need retrieval or further manipulation after introduction into the body. 
In degradable polymers, there is another level of classification based upon the 
mechanism of erosion. The term ‘degradation’ specifically refers to bond cleavage, whereas 
‘erosion’ refers to the depletion of material. Degradation is a chemical process whereas 
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erosion is a physical phenomenon reliant on dissolution and diffusion process. Two 
mechanisms of polymer erosion can be identified, surface and bulk erosion. In practical 
terms, these two mechanisms represent extremes. For most biodegradable polymers both 
mechanisms will occur, but the relative extent of surface or bulk erosion varies radically with 
the chemical structure of the polymer backbone. 
Surface erosion occurs when the rate of erosion exceeds the rate of water permeation 
into the bulk of the polymer. This is often considered to be a desirable mechanism of erosion 
in drug delivery because the kinetics of erosion as well as the rate of drug release is highly 
reproducible. The magnitude of the erosion may be changed by simply changing the surface 
area of the drug delivery device. The slow rate of water permeation into surface eroding 
devices has a further beneficial effect of protecting water labile drugs up to the time of drug 
release. Water permeation is retarded by designing the polymers with hydrophobic monomer 
units. Besides, hydrophobic components could be added to stabilize the polymer bulk. In 
ideal surface erosion, the erosion rate is directly proportional to external surface area. Surface 
erosion can lead to zero order drug release provided that diffusional release is limited and the 
overall shape remains constant. Bulk erosion occurs when water molecules are able to 
permeate into the bulk of the polymer matrix at a quicker rate than erosion. As a 
consequence, polymer molecules in the bulk may be hydrolyzed and the kinetics of the 
polymer degradation or erosion is more complex than for surface eroding systems. The 
majority of the biodegradable polymers used in controlled drug delivery undergo bulk 
erosion. While the more limited predictability of erosion and the lack of protection of drug 
molecules are inherent disadvantages to the bulk eroding systems, these properties do not 
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inhibit their successful employment as drug delivery devices. Many new applications in 
controlled release use nano and microparticle formations that posses mass surface areas 
resulting in bulk and surface eroding materials possessing similar erosion kinetics. Within the 
scope of biodegradable systems, natural polymers, particularly those in the poly (saccharide) 
family, are being investigated. They are referred as biopolymers, and synthesis of this class 
of polymers is limited to the manipulation of bulk material to enhance their viability. Due to 
the physicochemical limitations of natural materials, there is significant exploration of 
synthetic polymer which can be readily tailored to offer properties for specific applications. 
Degradation polymers can be limited to 1 month, depending on the desired range of 
therapeutic effect. The ability of designing biomaterials with specified release, mechanical 
and processing properties has opened opportunities for synthetic chemists in the controlled 
release area.  
Among the biodegradable polymers, poly (esters) is the best characterized and the 
most widely studied biodegradable polymer system. The synthesis of polyesters has attracted 
much interest as the degrading of these materials. The mechanism of the degradation in 
polyester materials is classified as bulk degradation with random hydrolytic scission of the 
polymer backbone. The well known polymer poly (lactic acid) (PLA) is a member of such 
class. Poly (esters) have been widely employed in drug delivery applications and 
comprehensively studied. The predominant synthetic pathway for production of poly (esters) 
is from ring-opening polymerization of the corresponding cyclic lactone monomer.  
Poly (esters) based on poly (lactic acid) (PLA), poly (glycolic acid)  (PGA), and their 
copolymers, poly (lactic acid-co-glycolic acid) (PLGA), are some of the best defined 
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biomaterials with regard to design and performance. Lactic acid contains an asymmetric 
alpha-carbon which is typically described as D or L form in classical stereochemical terms 
and sometimes as the R and S form. For homopolymers, the enantiomeric forms are poly (D-
lactic acid) (PDLA) and poly (L lactic acid) (PLLA). The physicochemical properties of 
optically active PDLA and PLLA are nearly the same, whereas the PLA has very different 
characteristics. Because the naturally occurring lactic acid is L, PLLA is considered more 
biocompatible. The polymers are derived from monomers that are natural metabolites of the 
body; therefore the degradation of these materials yields the corresponding hydroxyl acid, 
making them safer for in vivo use. Biocompatibility of the monomer is the foundation for 
biocompatibility of degradable polymer systems. To this end, the degradation products often 
define the biocompatibility of a polymer-not necessarily the polymer itself. Even though 
PLGA is extensively used and represents the gold standard of degradable polymers, 
increased local acidity due to the degradation can lead to irritation at the site of the polymer 
employment. Introduction of the basic salts has been investigated as a technique to control 
PH in local environment of PLGA implants.  
From a physical level of understanding, poly (esters) undergoes bulk degradation. 
PLA homopolymers degrade slower than PGA homopolymers on the basis of crystallinity as 
well as steric inhibition by the pendent methyl group of PLA to hydrolytic attack. Other class 
of polymers often used in drug release applications includes poly (ethylene glycol) block 
polymers, poly (ortho esters), poly (anhydrides) and etc. 
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1.4 Hydrogel in Controlled Release Applications 
 
Traditional delivery systems suffer from the limitations and disadvantages of minimal 
synchronization between the required time for therapeutically effective drug concentrations 
and the actual drug release profile exhibited by the dosage form. Controlled delivery systems 
through targeted drug delivery of a predetermined dose over a sustained period have been 
used to overcome the shortcomings of conventional dosage forms. This is mainly because the 
reason that controlled drug release system can offer sustained therapeutic level of drug 
concentration without introducing toxicity. Responsive drug release system would respond to 
physiopathological signals from an underlying disease. The appropriate amount of drug 
would be released based on the stimulation of such a physiopathological signal. 
Hydrogels are one of the upcoming classes of polymer-based controlled-release drug 
delivery system. The existence of hydrogels dates back to 1960, when Wichterle and Lim 
first proposed the use of hydrophilic networks of poly (2-hydroxyethyl methacrylate) 
(PHEMA) in contact lenses [4]. Since then, the applications of hydrogels have extended to 
various biomedical and pharmaceutical applications. In comparison to other synthetic 
biomaterials, hydrogels resemble living tissues closely related to their physical properties 
because of their relatively high water content and soft and rubbery consistency. Hydrogels 
show minimal tendency to absorb proteins from body fluids because of their low interfacial 
tension. Further, the ability of molecules of different sizes to diffuse into and out of 
hydrogels allows the possible use of dry or swollen polymeric networks as drug delivery 
systems for oral, nasal, ocular administration. Several terms have been named for hydrogels, 
such as smart gels and intelligent gels. The smartness of a material is critical to its ability to 
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receive, transmit or process a stimulus, and respond by producing a useful effect. Once 
activated, stimuli can result in changes in phases, shapes, optics, mechanics, electrical fields 
and etc. Hydrogels are smart or intelligent in the sense that they can perceive the stimuli and 
respond by exhibiting changes in their physical or chemical behavior, resulting in the release 
of entrapped drug in a controlled manner.  
A common misunderstanding in polymer science is the use of the terms ‘gel’ and 
‘hydrogel’ synonymously. As polymeric networks, both gels and hydrogels might be similar 
chemically, but they are physically different. Technically, gels are semi-solid systems 
comprising small amounts of solid, dispersed in relatively large amounts of liquid, yet 
possessing more solid-like than liquid like character. Hydrogels are also described as 
aqueous gels because of the prefix ‘hydro’. Although the term hydrogel implies a material 
already swollen in water, in a true sense hydrogels are a cross-linked network of hydrophilic 
polymers. They possess the ability to absorb large amounts of water and swell, while 
maintain their three dimensional structure. The definition differentiates hydrogel from gels, 
which are polymeric networks already swollen to equilibrium, and the further addition of 
fluids results only in dilution of polymeric network. Although some of the gels are rigid 
enough to keep their structure under a tiny stress, after exceeding the yield-value, gel fluidity 
is observed with loss of polymer structure. A hydrogel exhibits swelling in aqueous media 
for the same reasons that an analogous linear polymer dissolves in water to form an ordinary 
polymer solution. Thus, the feature central to the functioning of a hydrogel is its inherent 
cross-linking. Because the basic framework of both gels and hydrogels is the polymer 
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network, these polymers produce systems that span a range of rigidities, beginning with a sol 
and increasing to mucilage, jelly, gel and hydrogel. 
Hydrogels are considered to be a polymeric material that has the ability to absorb 
>20% of its weight of water and still maintain a distinct 3D structure. The hydrophilicity of 
the polymer imparts water attracting properties to the system. Their characteristic water-
insoluble behavior is attributed to the presence of chemical or physical cross-links, which 
provide a network structure and physical integrity to the system. Hydrogels are elastic in 
nature because of the presence of a memorized reference configuration to which they return 
even after being deformed for a long period. Hydrogels consist of polymers combined with 
water to create a solid with certain water like properties, such as permeability for many 
water-soluble substances. Hydrogels are available in various structural and chemical forms, 
on which basis they have been broadly classified. 
Traditionally, controlled release polymeric systems have been classified into matrix 
and reservoir types. Matrix systems are most commonly employed because of their ease in 
development, cost-effectiveness and better performance. However, these systems tend to 
follow Higuchi’s model, wherein drug release is proportional to the square root of time. This 
leads to non-uniform release rates, continuously decreasing in the beginning and more 
rapidly thereafter. They key benefit of hydrogels for controlled drug delivery lies in the near 
constant release rates.  
Preparation of hydrogel based drug product involves either cross-linking of linear 
polymers or simultaneous polymerization of monofunctional monomers or cross-linking with 
poly-functional monomers. Further, the mechanical strength of poorly cross-linked hydrogels 
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can be adequately enhanced by various methods. Polymers form natural synthetic or semi-
synthetic sources can be used fro synthesizing hydrogels. Usually, polymers containing 
hydroxyl, amine, amide, ether, carboxylane and suffocate as functional groups in their side 
chains are used.  
 
Figure 1-3 Polymer stands forming a gel and a hydrogel, showing different behavior in an 
aqueous environment. Solid circles represent covalent cross-links and hollow circles 
represent virtual cross-links formed by entanglements. 
14 
 
 
Figure 1-4 Schematic representation of the steps involved in preparation of a hydrogel-based 
drug delivery system. 
Most of the hydrogels are glassy in their dehydrated state, and drug release generally 
involves simultaneous absorption of water and desorption of drug via a swelling controlled 
mechanism. The rate-controlling factor mediating drug delivery is the resistance of the 
polymer to an increase in volume and change in shape. A glassy hydrogel, on coming into 
contact with water or any other thermodynamically compatible medium, allows solvent 
penetration into free spaces on the surface between the macromolecular chains. When 
enough water has entered the matrix, the glass transition temperature of the polymer drops to 
the experimental temperature. The presence of solvent in a glassy polymer causes the 
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development of stresses that are accommodated by an increase in the radius of gyration and 
end-to-end distance of polymer molecules, which is seen macroscopically as swelling. The 
movement of solvent into the dry polymer matrix takes place with a well defined velocity 
front and a simultaneous increase in the thickness of the swollen region with time in the 
opposite direction. Such swelling and diffusion do not generally follow a Fickian diffusion 
mechanism. The existence of a slow macromolecular relaxational process in the swollen 
region is believed to be responsible for the observed non-Fickian behavior. 
The past few years have witnessed great advances in polymer-based controlled 
release drug deliver system .Several products displaying constant or decreasing releasing rate 
have progressed from the lab to the clinic in the short period of time. Most of these systems 
are therapeutically advantageous over conventional systems, but are insensitive to changing 
metabolic states in the body. To synchronize the drug release profile with physiological 
conditions, mechanism are responding to physiological variations must be provided. An ideal 
drug delivery system should respond to physiological requirements, sensing the changes and 
accordingly change the drug-release profile as desired. Thus, drug delivery patterns need to 
be optimized for pulsed or self-regulated mechanisms. 
Hydrogels can exhibit dramatic changes in their swelling behavior, network structure, 
permeability or mechanical strength in response to different stimuli, both internal and 
external to the body. Various stimuli that have been explored for modulating drug delivery 
are presented in Figure 1-5. The mechanisms of action of these stimuli on structural changes 
in the polymer network and corresponding modulation in drug release have been well 
studied. External stimuli have been produced with the help of different stimuli generating 
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devices, whereas internal stimuli are produced within the body to control the structural 
changes in the polymer network and to exhibit the desired drug release. Much research has 
been directed towards single-stimulus responsive hydrogel for drug delivery. This might not 
be advantageous in pathological conditions with more than one physiological stimulus 
present, where drug release is required in the presence of both stimuli rather than a single 
one. 
 
Figure 1-5 Stimuli responsive of swelling of hydrogels 
Variations in pH are well known to occur at several body sites, such as the gastro-
intestinal sites and blood vessels. The pH variations of these locations can provide a suitable 
base for pH sensitive drug release. Besides, local pH changes in response to specific 
substances can be generated and used for modulating drug release. The pH-responsive drug 
delivery system has been targeted for controlled drug release. pH responsive hydrogels are 
composed of polymeric back-bones with ionic pendant groups. Most commonly studied ionic 
polymers for pH sensitive behavior include poly (acrylamide) (PAAm), poly (acrylic acid) 
(PAA), poly (methacrylic acid) (PMAA) and poly (dimethylaminoethylmethacrylate) 
(PDEAEMA) and poly (dimethylaminoethylmethacrylate) (PDMAEMA). In aqueous 
medium of appropriate pH and ionic strength, the pendant groups ionize and develop fixed 
17 
 
charges on the polymer network, generating electrostatic repulsive forces responsible for pH 
responsive swelling or deswelling of the hydrogel, thereby controlling the drug release. Small 
changes in pH can result in significant change in the mesh size of the polymeric networks. 
Pedant groups of anionic hydrogels are un-ionized below and ionized above the pKa of the 
polymeric network, leading to swelling of the hydrogel at a pH above the polymer pKa 
because of a large osmotic swelling force by the presence of ions. The reverse is the same for 
cationic hydrogels, which swells at lower pH. Differential swelling of ionic hydrogels in 
acidic and alkaline buffers is present in Figure 1-6. 
 
Figure 1-6 The pH responsive swelling of (a) anionic and (b) cationic hydrogels. 
Apart from the use of synthetic polymers, various natural polymers, such as albumin 
and gelatin have also shown pH responsive swelling behavior. Under appropriate conditions 
of pH and temperature, the linear polymers form helices in regions stabilized by extensive 
hydrogel bonding. These helices function as cross links holding the amorphous regions 
together. These proteins with minimal surface charge at their isoelectric point show extensive 
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swelling at a pH away from their isoelectric point because of the development of high surface 
net-charge and increased electrostatic repulsive force.  
 Among the polymers that can respond to external stimuli, poly (N-
isopropylacrylamide) (PNIPAAm) hydrogel has been widely examined as a smart drug 
delivery material due to its unique phase separation behavior upon external temperature 
changes. PNIPAAm hydrogels are well known for their discontinuous phase separation near 
their phase transition temperature or lower critical solution temperature (LCST) and exhibit a 
sudden shrinking in volume at a temperature right above LCST. This transition is mainly 
controlled by the rapid alternation in hydrophilicity and hydrophobicity among the hydrogel 
sub-groups, and thus structural collapse takes place upon heating. 
Various studies have proposed a novel class of hydrogels that exhibit pH and 
temperature sensitive swelling property. These materials could rove extremely useful in 
enzymatic applications and protein drug delivery. Hydrogels made of poly (N-
isopropylacrylamide) PNIPAAm and PAA exhibited dual sensitivities. PNIPAAm is well 
known for its temperature sensitivity, and PAA and PMAA show pH sensitivity. These kind 
of hydrogels were able to respond rapidly to both temperature and pH changes. The 
application of this type of hydrogel has been used for the delivery of insulin and calcitonin. 
This type of polymers has also been engineered to gain faster respond time. Major factors 
that affect the degree of swelling of ionic polymers include the properties of the polymer, 
such as charge, concentration, and pKa of the ionizable group, degree of ionization, cross-
link density and hydrophilicity or hydrophobicity, as well as the properties of the swelling 
medium.  
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1.5 State of the Art Controlled Release Systems  
 
Increasing efforts have been put into developing controlled release systems. Most of 
the recent controlled release systems employ smart materials as one of the most important 
component. As introduced in the previous sessions, these systems are usually 
environmentally sensitive. Several state of the art controlled release systems which are 
published recently are introduced in this session. 
Abidian M. R.  et al. reported a controlled release system employing conducting 
nanotubes, which are fabricated through conducting polymers [5]. Conducting polymers are 
of considerable interest for a variety of biomedical applications. Their responds to 
electrochemical oxidation or reduction can produce a change in conductivity, color and 
volume. A change in the electronic charge is accompanied by an equivalent change in the 
ionic charge, which requires mass transport between the polymer and electrolyte. 
Electrochemical actuators using conducting polymers based on the principle have been 
developed by several groups. They can also be used to dope with bioactive drugs, and can be 
used in actuators such as microfluidic pumps. The researchers reported that their method can 
be used to precisely control drug release. The fabrication process involves electrospinning of 
a biodegradable polymer, into which a drug has been incorporated, followed by 
electrochemical deposition of a conducting polymer around the drug loaded, electrospun 
biodegradable polymers. This will lead to a decrease of the impedance and increase of the 
charge capacity of the recording electrode. The controlled release is realized through 
responding to electrical stimulation applied on nanotubes. 
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Conducting nanotubes are prepared using poly pyrrole (PPy) and poly (3,4-
ethylenedioxythiophene) (PEDOT) in templated nanostructures for neural prosthesis 
applications. It is significant to minimize the electrode impedance for obtain high quality 
signals and PPy and PEDOT show potential in improving signal quality. PEDOT tubes have 
a well-defined internal and external surface texture further decrease the electrode impedance 
by increasing the effective surface area for ionic to electrode charge transfer to occur at the 
interface between brain tissue and the recording site. The release of dexamethasone can be 
precisely controlled by external electrical signals. Nanofibers were prepared firstly by 
electrospinning biodegradable PLLA or PLGA on the surface of a neural probe, and then 
deposit conducting polymers electrochemically.  
 
Figure 1-7 Schematic diagrams illustrating the surface modification of neural 
microelectrodes to create nanotubular PEDOT. A) Electrospinning of PLGA fivers. B) 
Electrochemically polymerization of conducting polymers. C) Dissolving the electrospun 
fibers to create nanotubular conducting polymers. E) Gold electrode surface F) The electrode 
surface after electrospinning of nanofibers. G) Electrode after electrochemical deposition of 
PEDOT polymers. H) Electrode after removal of core nanoscale fiber templates. 
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In their work, the decrease of impedance of the neural microelectrodes can be 
significantly decreased by about two orders of magnitude and the charge transfer capacity 
also increased dramatically by creating conducting polymer nanotubes on a gold electrode 
surface. Individual drugs and bioactive molecules are controllably released at desired points 
in time by using electrical stimulation of the nanotubes. 
 
Figure 1-8 SEM micrographs of PLGA nanoscale fibers and PEDOT nanotubes.  A) PLGA 
electrospinning fibers. B) Silicon substrate layer and PEDOT coating. C) PEDOT nanotubes 
crossing each other. D) Higher magnitude of C. E) Single PEDOT nanotube polymerized 
around a PLGA fiber. F) High magnitude E. 
  Slowing I.I. et al. reported a new structure called “Mesoporous silica nanoparticles” 
(MSN) as controlled release drug delivery and gene transfer carriers [5]. Mesoporous silicas, 
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which are composed of a honeycomb-like porous structure with hundreds of empty channels 
(mesopores) that are able to absorb and encapsulate relatively large amounts of bioactive 
molecules. The unique properties, such as large pore volume and high surface area, and good 
chemical and thermal stability make them potentially suitable for various controlled release 
applications. While the meoporous silica nanospere are potentially useful for many 
significant applications in biotechnological and biomedical areas, these materials cannot be 
used as efficient agents for gene transfection or carriers for intracellular drug delivery 
because the mammalian cells cannot efficiently engulf large particles via endocytosis. 
 
Figure 1-9 TEM images of MSN. 
Besides, MSNs are within the size window of bacteria and could potentially trigger 
acute immune response in vivo. To circumvent these problems and concerns, they developed 
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a synthetic approach for preparing a series of mesoporous siclica nanoparticles materials. The 
MSNs has several advantages over conventional counterparts, such as tunable particle size, 
stable and rigid framework, uniform and tunable pore size and etc. TEM of MSN particles 
are reprinted in Figure1-9. MSN based controlled release systems have demonstrated to be 
able to delivery different kinds of guest molecules. The loading is usually in the order of 
hundred milligrams per gram of MSN. The molecules that have been used the most are 
imaging agents, such as fluorescein, texas red, and rhodamine B, with the main goal of 
testing the working principle of the stumulus controlled release drug and gene delivery 
system.  
Radt et al. developed controlled release system using NIR laser [21]. Such a system is 
reacted to heat as a source stimulus. The microcapsule was intact before several nano 
seconds of NIR laser activation; however, after the activation of NIR laser nanocomposite 
capsule shell will rupture due to the presence of the metal nanoparticles as shown in Figure 
1-10. Similarly, Shchukin et al. developed a ultrasound irritated system for drug release [11] 
(Figure 1-11). The disadvantage of these methods involves in complicate fabrication process, 
besides, shell rupture mechanism does not support sustained release, which means break shell 
also breaks the control mechanism simultaneously. 
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Figure 1-10 Optically addressable nanostructured capsules of polyelectrolyte multilayers 
containing gold nanoparticles are prepared via layer-by-layer colloid templating. The 
nanocomposite capsule shell, due to the presence of the metal nanoparticles, can be 
addressed with laser light in the near-infrared (NIR) to induce morphological changes in the 
capsules. Enzyme encapsulated within these capsules is released remotely and on demand 
with nanosecond laser pulses in the NIR, while retaining its activity.  
 
 
Figure 1-11 SEM (bottom panels) and fluorescence confocal (top panels) images of the 
Fe3O4/polyelectrolyte capsules, which were incubated at 70 °C for 90 min, treated by 
ultrasound (500 W) for different time durations. 
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1.6 Challenges 
 
Although controlled release systems have been extensively investigated in recent 
years, there still exist challenges in moving toward clinical usage with more efficiency, from 
both therapeutic effects and cost. Obviously, the success of this method hinges upon the 
ability to construct a biocompatible carrier that allows high loading of drug molecules 
without any premature release of the cargo before reaching the destination or a pre-define 
period of time. There are still many problems and concerns in real applications. 
As stated in the previous sections, a variety of materials, polymers and hydrogels are 
already available due to the fast development of materials science and engineering. Although 
biocompatibility and biodegradability are the major concerns of using these carrier and 
actuator materials, other aspects of these materials need to be considered. For example, 
carrier material is used as a component in the drug delivery system and the compatibility of 
such material with respect to the drugs should be tested. The addition of carrier materials 
should not impact or interact with the drug pharmaceutical property. Otherwise, certain 
isolation mechanism is necessary to isolate the carrier material and drugs which obviously 
make the system design even complicated. Besides, carrier materials used in the controlled 
drug release system need also be compatible with fabrication process. Harsh fabrication 
process will denature material properties; these processes include high temperature, high 
pressure, chemical reactions and etc. These materials should keep their chemical and physical 
properties after fabrication process. All the actual concerns and problems make the selection 
of an appropriate material in a system a very difficult and significant step. 
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(a) Matrix diffusion system. 
                  
(b) Reservior release system 
Figure 1-12 Matrix and reservoir system. 
 How the carrier and actuator materials will assist the controlled drug release is 
another difficulty in the design process. There are many different choices of integrating drugs 
and carrier, such as embedding drugs in the polymer matrix and encapsulating drugs in a 
hollow carrier material compartment, as shown in Figure 1-12. The employment of 
integration format depends on the device requirements, such as drug loading capacity and 
drug regulation profile. Current drug delivery applications favor a high loading capability to 
reduce the cost of carrier materials as will as the size of the device. The integration of drug 
and its carriers should add minimum volume compared to the drug itself. In terms of this, 
encapsulation of drugs method is more effective than embedding drugs in carrier matrix. 
However, encapsulation usually requires a more complicate and delicate fabrication process. 
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Leakage is another important concern in real applications. Here, leakage is defined as 
the amount of drug released during device travelling to desired location, or during the period 
of time in which the device is waiting for certain receptor or stimulus. All these premature 
release is highly undesirable, which will impact the prior efforts in improving drug loading 
and the total effectiveness of the drug release system. Therefore, leakage is a good criterion 
to check how good the carrier material is to resist body environment during travelling as well 
as how effective the control mechanism when there is zero stimulus. Therefore, controlled 
release mechanism with the ability to respond to certain stimulus is highly preferred 
comparing to conventional diffusion release system where leakage is a major concern.  
The easiness of fabrication to achieve a certain drug delivery system decides the cost 
and time in the developing process. Previous examples shown above employ smart or 
intelligent control mechanism (electrical, NIR, ultrasound and etc.) to release internal 
loadings. However, the fabrication process is non-trivial. Complicated multiple steps 
involves in these processes which will also bring difficulties in materials selection. 
Last but not least, the release rate and the response of the controlled drug release 
system is another critical factor. A proper rate of release is needed to quickly achieve an 
effective local concentration. These features depends not only on the control mechanism 
employed, however, also rely on the smart materials employed in the systems.  
Highly integrated fabrication process employing elelctrospinning technique 
incorporated with intelligent hydeogel material  in drug release control mechanism is the core 
of  this work. Such sytems could be further applied in pharmaceutics, biomeidical science 
and biotechnologies. 
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CHAPTER 2. ELECTROSPINNING TECHNIQUE 
2.1 Introduction to Electrospinning 
 
Electrospinning, a technique first patented in 1934 and first known as ‘electrostatic 
spinning’ in 1993, is widely used to produce high volume continuous ultrathin fibers  and is 
drawing more research interests since 2000 (Figure 2-1 [12]). Comparing with other 
techniques producing fibers or other one dimension structures, such as mechanical drawing, 
chemical synthesis, electrospinning is a ‘drawing’ method based on electrostatic interactions 
and is one of the simplest methods with high efficiency in producing fibers with nano and 
micrometer resolutions. These advantages of electrospinning make it a promising technique 
in traditional textile engineering. Besides, continuous electrospun fibers with high surface 
area show application potentials in neural and tissue engineering.  
 
Figure 2-1 Annual Number of Publications on the subject of electrospinning. 
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Over the last decades, over thirty synthetic and natural polymers were successfully 
electrospun into fibers with diameters varying from nanometers to micrometers. Polymers 
which could be used in electrospinning include water soluble polymers such as poly 
(ethylene oxide) (PEO) and poly (vinvy alcohol) (PVA), and many types of polymers needs 
organic solvents such as poly lactide (PLA), poly styrene (PS), poly (methylmethacrylate) 
(PMMA), polyamides, polyimides, polycaprolactone, and polyvinvylidene fluoride. Figure 2-
2 shows the product of electrospinning fibers from different polymers.  
 
Figure 2-2 Electrospun nanofibers from different polymers. (a) Cellulose acetate from 5% 
solution in dichloromethane/ethanol, 9:1, (b) Polyvinylidene difluoride from 15% solution in 
dimethylformamide/tetrohydrofuran, 1:1. 
A basic electrospinning setup contains at least three components: A DC voltage 
power supply (usually can provide up to several kilo-volts voltage), a grounded conductive 
collector and a spinneret (needle) loaded with electrospinning materials (polymers or other 
composites). High DC voltage is applied at the end of the spinneret and a high electrical field 
is formed between the spinneret and the grounded conductive collector. Under such a high 
electrical field, liquid polymer at the nozzle of the spinneret is electrified and charges are 
induced on the polymer surface. A ‘Taylor cone’ structure is formed due to the electrostatic 
repulsion between surface charges and Coulombic force exerted by the electrical field. When 
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the electrical force overcome the Taylor cone surface tension, liquid jet will eject from the 
nozzle towards the conductive grounded collector. With the evaporation of polymer solution, 
fibers are deposited randomly on the grounded collector surface.  
Electrospinning is a multi-factor process involving electrostatics, hydrodynamics, and 
mechanics. The formation of Taylor cone and the ejection of polymer liquid jet by external 
electric field is a coupled electro-hydrodynamics problem which attracts considerable 
research interests. It was initially misunderstood that multiple jets ejected from the Taylor 
cone simultaneously due to its high speed jet motion, however, recent high speed photograph 
proves that the conical envelope contains only one very fast moving jet with irregular moving 
trajectory. Theoretical efforts are trying to interpret this complicate electro-hydrodynamics 
phenomenon. Reneker D.H. et al. developed a general electro-hydrodynamics model of a 
weakly conductive viscous jet accelerated by an external electrical field [7]. The model takes 
into account inertial, hydrostatic, viscous, electrical and surface tension factors. Polymer 
fluid was described by nonlinear rheologic constitutive equation. This mathematics model 
agrees with experimental electrospinning process. This theoretical analysis will help in 
understanding the issues and difficulties in designing new experiments.  
The versatility of electrospinning also exhibits on its compatibility on different 
materials. Such a great feature has gained significant attention due to the huge application 
potential for manifold applications in optics, electronics, biology, medicine, and etc. Many 
natural and synthetic polymers have been successfully used in electrospinning process. Water 
soluble poly (ethylene oxide) (PEO) has been widely used with or without the addition of 
another type of polymer. PEO solutions were used in electrospinning to investigate the 
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fundamental properties of experimental properties. Synthetic polymers such as water non-
soluble poly (lactic acid) (PLA), poly (lactic-co-glycolic acid) (PLGA) are also widely used 
polymers in electrospinning applications. 
 
Figure 2-1 Basic Electrospinning Setup [23] 
Natural macromolecules are recently found to be compatible with electrospinning; 
collagen and fibrinogen have been processed into fibrous non-woven scaffolds for 
biocompatible applications. Although the eligibility of multi types of polymers has enhanced 
the application of such technique to a great extend, other contributions have focused on the 
preparation of ultrafine fibers through electrospinning using materials other than polymers. 
Metal oxide electrospun fibers, such as TiO2 and CuO have been published. Pure copper 
metal electrospun fibers have recently been reported [13]. Long copper nanofibers were 
prepared by electrospinning of copper nitrate-polyvinylbutyral (PVB) solutions to composite 
fibers followed by thermal treatment in air and then followed by thermal treatment in a 
hydrogen atmosphere. With the join of metal and metal oxide nanofibers, applications of 
32 
 
electrospinning have been greatly enhanced due to better mechanical properties and thermal 
stabilities. 
 
Figure 2-2 The evolution of the shape of a fluid drop in selected images from a video in 
which a new image was recorded every 2 ms. 
 
Figure 2-3 Microscopic image of sub-micrometer copper fibers on a thin mica slide [13]. 
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2.2 Applications of Electrospinning 
 
The development of electrospinning technique was driven and accelerated by the 
multi-disciplinary applications of electrospinning products. Recently, there is an increasing 
growing trend in the production and deliberate manipulation of nanoscale 3D structure to 
study cell functions in tissue engineering. The key tasks of tissue engineering are to create a 
two dimensional or three dimensional scaffolds with suitable degradation rate to meet the 
requirements of new tissue growth; to supply interconnected pores for cell-cell and cell-
matrix communications and to bring cells together to form a tissue. Three methods could be 
used for the fabrication of nanofibrous scaffolds, which are phase separation, self assembly 
and electrospinning. As already proved, many synthetic and natural materials, including 
biocompatible and biodegradable could be applied in electrospinning technique. These 
materials include but not limited to collagen, poly (e-capralactone) (PCL), ploy (D-lactide) 
(PDLA) and poly (L-lactide) (PLLA). Electrospinning offers a rapid and effective way to 
produce scaffolds with nanoscale elements and has been applied across a board range of 
synthetic and natural polymer systems. The highly porous electrospinning scaffolds offer a 
wide variety of topographical features to support cellular adhesion and proliferation. It is well 
known that extracellular environment influences many aspects of cell behavior such as cell 
morphology, functionalities and cell-cell interactions. Electrospinning fibrous scaffolds could 
be engineered to change the porosity, mechanical strength, and other parameter to better 
study the effect of ECM to the growth of cells. Besides, the random nature of the fibers could 
be changed to get fibers with special pattern and orientation. These oriented fiber scaffold 
can be used to guide the cell growth and related studies. However, there are still many 
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unknown factors such as the best fiber diameter and the average distance between internal 
neighbor fibers to optimize cell function. Another obstacle to mimic the natural ECM using 
electrospinning scaffolds lies in the bio-mechanical property of fibers. Other materials, such 
as polymeric-ceramic composite fibers have been investigated to enhance fiber bonding and 
mechanical properties. Recently, more efforts have been put to develop 3D fibrous structure 
to further mimic the architecture, functionalization and interfacial properties of natural ECM. 
The application of electrospinning products has been extended to highly sensitive 
detection techniques [8]. Electrospun nanofibrous membrane has been applied in highly 
sensitive and cost effective optical sensors. The underlying principle of such an application 
is: the sensitivity of a sensor that detects analytes by interacting with molecules on the 
surface will increase with increasing surface area per unit mass. Therefore, increasing the 
sensing surface area is important for detection sensitivity. An inherent nature of 
electrospinning fibrous structure is its high surface to volume ratio. Electrospun nanofibrous 
membranes could have approxiamately 1 to 2 orders of magnitude more surface area than 
conventional thin films. It is therefore believable that the large surface area of electrospun 
nanofibrous membranes has the potential to provide unusually high sensitivity detection 
ability in sensing applications. Wang et al. reported using electrospun nanofibrous 
membranes as highly responsive fluorescence quenching-based optical sensors for metal 
ions. A fluorescent polymer, poly (acrylic acid)-poly (pyrene methanol) (PAA-PM) was used 
in this application as an sensing material. Their preliminary results show that the sensitivities 
of electrospun nanofibrous membranes to detect metal ions are 2 to 3 orders of magnitude 
higher than those obtained from traditional thin film sensors. 
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Figure 2-3 Immunofluorescent staining of adherent MC3T3-E1 cells has been super-imposed 
onto a phase contrast image of PDLLA fibers (red). The green corresponds to vinculin and 
the blue is the actin. 
 
Figure 2-4 SEM images of electrospun nanofibrous membrane as highly sensitive detectors 
[8]. 
Electrospinning fibers have also been successfully applied in drug release area. 
Polymeric drug delivery systems have numerous advantages compared to conventional 
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dosage forms, such as improved therapeutic effect, reduced toxicity, convenience and etc. 
Bio-degradable polymers provide sustained release of encapsulated drugs and degrade in the 
body to nontoxic, low molecular weight product that is easily eliminated. However, there are 
still many problems to be solved, such as the low efficiency of preparing nano and micro 
particles and vesicles is not high, and the control and regulation of the drug release profile. 
Recently, researches have shown that drugs can be encapsulated directly into electrospun 
fibers and these systems showed nearly zero order kinetics of drug release. In some 
applications, poly(L-lactide acid) (PLLA) was used as a carrier to contain drugs, additional 
surfactant might be added to change the diameter of the fibers in order to regulate the 
dynamics parameter as well as degradation time of the drug release systems. Drugs are mixed 
with the carrier and produced in the form of nano and micro fibers and are released from the 
fibrous membranes. The drug release profile and polymer matrix degradation profile are 
functions of electrospun fiber characteristics and carrier properties.  Due to the cost-effective 
high yield nature of electrospinning process, electrospinning seems to be the only method 
which can be further developed for large scale production of continuous nanofibers for 
industrial applications.  
Another area nanofibers involve in is filtration which is very necessary in many 
engineering fields [9]. Fibrous materials used for filter media provide advantages of high 
filtration efficiency and low air resistance (Figure 2-5). Filtration efficiency associates 
closely with the fiber fineness, which is one of the most significant factors in filter 
performance. Beside the applications mentioned above, electrospinning products have a 
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broad range of applications, such as materials science and engineering, textile engineering, 
biomedical engineering, electrical engineering and etc. 
 
Figure 2-5  FESEM micrographs of electrospun PVDF membrane (a) before and (b) after 
heat treatment. 
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2.3 Co-axial Electrospinning 
 
Core-shell fibers, as another one dimension nanostructure start to draw interests, since 
core-shell structures could further enhance material properties for the single layer fiber 
applications. There exist multiple fabrication technology to fabricate core-shell nanofibers, 
including template coating, laser ablation and etc. Another powerful feature of 
electrospinning is the ability to produce core-shell structures. Sun et al. reported their work 
of using co-axial electrospinning (co-electrospinning) to produce core-shell fibers of two 
types of polymers. With co-electrospinning, two components can be coaxially and 
simultaneously electrospun through different feeding capillary channels to generate 
composite nanofibers in the form of core-shell structure. In their research, nanometer core-
shell fibers made of two polymers poly (ethylene oxide) (PEO) and polysulfone (PSU) were 
fabricated using co-electrospinning [10].  
Another successful application of using co-electrospinning is to fabricate hollow 
fibers. It has been demonstrated that a variety of materials such as polymers, ceramics and 
carbon could all be prepared as uniform fibers by electrospinning, with controlled size, 
compositions and morphologies. McCane et al. shows that with the use of a coaxial, dual 
capillary spinneret hollow titania fibers could be fabricated using co-electrospinning. 
Fabrication of hollow fibers by co-electrospinning a poly (vinvy pyrrolidone) (PVP) solution 
containing a titanium alkoxide and mineral oil, followed by selectively removal of the liquid 
core and calcination. The inner diameter and wall thickness of these hollow fibers could be 
readily varied from tens nanofibers to several hundred of nanometers by controlling the 
experimental parameters. 
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Figure 2-6 TEM of compound nanofibers. Core and shell solutions are PSU and PEO 
respectively [10]. 
 
Figure 2-7 Hollow fibers fabricated by co-electrospinning [14]. 
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Figure 2-8 Schematic illustration of the setup that used a dual-capillary spinneret to directly 
electrospun hollow fibers [14]. 
Encapsulation is a common approach for protecting substances of interest from harsh 
environments. Within this broad setting, there are situations in which it is important that the 
encapsulated materials are divided into tiny quantities with characteristic sizes in the micro 
or nanometer range. Examples can be found in drug delivery, where, in order to survive and 
overcome biological barriers, capsules carried in the blood stream need to have diameters 
smaller than a certain threshold, usually below a few hundred nanometers. There are many 
different methods in which the final product consist of clusters of micro or nanocapsules in 
the form of powder, or dispersed in the form of an emulsion. The framework of 
encapsulation has been broadened by the use of electrified coaxial micro and nanojets for 
coaxial electrospinning of two different liquids. This method allows one step fabrication of 
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micro and nano tubes. The products of co-electrospinning are all structures with radial 
anisotropies. Co-electrospinning has been used to encapsulate labile materials other than 
polymers within fibers. However, there are many situations in which hydrophobic materials 
need to be encapsulated by hydrophilic polymers in the form of fibers. There requirements 
exist in drug delivery and cosmetics. Co-electrospinning provides a simple solution for such 
a complicate structure which would have applications in various technological fields, such as 
drug delivery [11].  
 
Figure 2-9 Optical Images of PVP-oil fibers.(a) visible light (b) UV light (c) overlap of (a) 
and (b).[11] 
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CHAPTER 3. SELECTIVE  DEPOSITION OF ELECTROSPUN 
NANOFIBERS USING MICROFLUIDIC CONFINEMENT 
APPROACH 
 
3.1 Introduction to Electrospun Fiber Patterning 
 
Electrospinning is an economical and versatile technique to fabricate continuous 
nanofibers [12]. The basic principle of electrospinning is that a Taylor cone of a polymer 
solution is formed at the tip of a metallic spinneret by applying a high voltage between the 
spinneret and a grounded collector. When the electrostatic repulsion within the charged 
polymer solution overcomes the surface tension, a charged fluid jet is ejected out of the 
spinneret, traveling through the air with solvent evaporation. Finally, nanofibers are 
deposited on the collector. A number of polymeric, metallic, and ceramic nanofibers have 
been realized through electrospinning [13,14]. Among them, electrospun nanofiber 
biomaterials possess highly porous structures with numerous interconnected nanopores, 
resembling the architecture of natural extracellular matrix (ECM). Therefore, nanofiber-
based artificial ECM scaffolds have recently attracted much attention and have shown great 
promises for musculoskeletal, skin, vascular, and neural tissue engineering applications, 
where they serve as excellent frameworks to improve cell adhesion, proliferation, and 
differentiation [14-21]. 
To maximally mimic natural ECM scaffolds, it is crucial to develop the ability of 
creating structurally complex and high-definition shapes of nanofibers on substrates. For 
example, research on regenerative medicine has revealed that tissue formation relies 
considerably on the spatial orientation and distribution of the artificial scaffolds that control 
43 
 
and guide cell growth and proliferation [22]. However, achieving micro-sized, structurally 
accurate, arbitrary-shaped patterns of nanofibers remains challenging. Current research to 
this topic is carried out in three major areas. The first area is to control the spatial orientation 
of nanofibers on collectors by overcoming the random deposition process of conventional 
electrospinning [23-33]. In this area, nanofiber alignment has been successfully 
accomplished by manipulating the applied electrostatic field through various modifications to 
collectors, including using paired conductive silicon strips separated by a void gap [23], 
multiple metal electrodes with particular configurations formed on an insulting substrate 
[24], and two pieces of conductive blades placed in line with a gap in between [25]. Other 
interesting fiber alignment strategies include the use of a rotating collection drum,
 
a wheel-
like bobbin or metal frame,
 
and near-field electrospinning [26, 27].
 
 The second area aims at 
forming patterned electrospun mats to realize controlled spatial distribution of nanofibers. To 
this end, many important and promising technologies have been reported. For example, 
conductive collectors with insulating regions of different areas and geometric shapes [30], 
woven wire fabric substrates [31], and enamel-coated steel sheets [32] have been employed 
to obtain electrospun mats with different patterned architectures. The third area is related to 
the selective deposition of nanofibers in discrete regions on collectors [33-39]. In this 
direction, movement of a collector during electrospinning provides a straightforward 
approach to discrete placement of nanofibers [34]. The resulting nanofiber patterns, however, 
have a low definition of shapes at the millimeter scale. Although electrodynamic focusing of 
nanofibers has been demonstrated to achieve micro-spots of nonwoven nanofibers on a 
collector, this technology requires a secondary electric field created by a specially designed 
electrostatic lens [35],
 
or a metal-coated shadow mask [36].
 
 Recently, conventional 
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photolithography has also been utilized to form discrete nanofiber patterns, although 
maintaining the morphological appearances and material properties of electrospun mats after 
multiple processing steps (spin coating of photoresist, soft baking, exposure, development, 
dry/wet etching) still remains a challenge.
 
Other technologies for selective formation of 
nanofibers include using electrical discharge
 
and femtosecond laser micromachining.
 
We 
present a simple and versatile method for selective deposition of nanofibers using a unique 
microfluidic collector, allowing formation of high-definition micro-patterns of nanofibers on 
a glass substrate for cell biology and tissue engineering. This research falls in the third area 
mentioned above. 
 
Figure 3-1 Process for selective fiber deposition. (a) The hydrophilic and hydrophobic 
regions are selectively patterned on the fiber collector surface using the photocleavable SAM 
technology. (b) The water-containing fiber etching solution is flowed to t the hydrophilic 
region via microfluidic filling, and is confined to that region due to the surrounding 
hydrophobic surface. (c) The fibers are deposited onto the modified fiber collector using 
electrospinning. (d) The etching solution dissolves the fibers in the hydrophilic region. (e) 
Polymer residue from the hydrophilic region is washed away by flowing the refresh etching 
solution into that region. (f) The fiber patterns are formed. 
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3.2 Concept of Microfluidic Patterning of Electrospun Fibers 
 
Figure 3-1 illustrates the principle and process of the proposed technology for 
selective deposition of nanofibers. The method is to selectively pattern the affinity of 
different regions of the collector surface for appropriate water-containing fiber etching 
solution. The pattern region is hydrophobic that repels the etching solution; while its 
peripheral region is hydrophilic that attracts the etching solution (Fig. 3-1a). These regions 
are patterned by means of photocleavable self-assembled monolayer (SAM) technology that 
allows transferring hydrophobic/hydrophilic patterns from a photo mask to the fiber collector 
surface (described in the Experimental Section) [41].
 
The fiber etching solution used here is 
either pure water or a mixture of water and suitable organic solvent that is fully miscible with 
water or has an acceptable solubility in water (SW). The water-containing etching solution is 
flowed to the hydrophilic (wet) region through a simple microfluidic capillary filling process, 
and is stably confined to the hydrophilic region without crossing the hydrophilic-
hydrophobic line to the hydrophobic (dry) region (Figure 3-1b). Therefore, a unique 
microfluidic collector is formed, where the dry pattern region is separated from the wet 
etching region. During electrospinning, the fibers pile up on the dry surface, while all other 
fibers are dissolved by the etching solution on the dry surface (Figures 3-1 c-d). Finally, the 
polymer residue from the wet surface is washed by the refresh etching solution carefully, 
leaving the nanofiber patterns in the dry region (Figures 3-1 e-f). In this method, the pattern 
definitions are determined by the predetermined patterns on the photo mask and by the lateral 
over-etch at the edges of the nanofiber patterns. By defining the shape of the patterns on the 
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photo mask, it is possible to realize arbitrary-shaped patterns of nanofibers. It should be 
noted that because a rather wide variety of organic solvents are available to mix with water to 
obtain proper water-containing etching solution (described in the Results and Discussion 
section), the presented selective deposition technique is applicable to a broad range of 
nanofiber materials.  
3.3 Experimental Section 
 
Materials: Two typical biomaterials are used to demonstrate the method: water-
soluble polyethylene oxide (PEO), and water-insoluble poly-DL-lactic acid (PDLLA). PEO 
(M.W. = 1,000,000), chloroform (HPLC grade, 99.9 %), fluorescein (pure, M.W. = 332.3), 
ethanol (100 %), are obtained from Sigma Aldrich (St.Louis, MO). Hydrofluoric acid (49 %) 
and acetone are obtained from Fisher Scientific (Pittsburgh, PA). PDLLA (i.v. = 0.69) is 
obtained from Lactel Polymers (Birmingham, AL). All reagents are used as received without 
further purification.  
Precursor Preparation: 30 wt/wt % PEO in ethanol is prepared by dissolving 
appropriate amounts of PEO powder in 70 % ethanol. The resulting mixture is further stirred 
by ultrasound for 6 hours at room temperature to obtain homogeneous and clear solutions 
without particulate materials. 12 wt/wt % PDLLA precursor is prepared by dissolving 
appropriate amount of PDLLA pellets into chloroform. The mixture is vigorously stirred 
after 24 hours at room temperature when the PDLLA pellets are fully dissolved in 
chloroform.  
Selective Surface Patterning of SAM: The photocleavable SAM technology is used to 
pattern the hydrophobic and hydrophilic regions on the fiber collector surface (Figures 3-2a-
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d). Briefly, a glass slide surface is flushed with a mixture of 0.5 wt% octadecyltrichlorosilane 
(OTS) in hexadecane to form a hydrophobic SAM. The SAM surface is rinsed with hexane 
and methanol sequentially, and then is dried using nitrogen. Ultraviolet (UV, 365 nm) light is 
used to expose the SAM surface through the photo mask in the pH = 11.6 NaOH 
environment for 85 mins. The UV irradiated surface becomes hydrophilic, while the 
unirradiated one remains hydrophobic. As a result, water-containing etching solution can be 
confined to the hydrophilic region (Fig. 3-2f). 
Microfluidic Capillary Filling and Confinement of Fiber Etching Solution: De-
ionized (DI) water is chosen to etch unwanted PEO fibers in the hydrophilic region. A 
number of organic solvents can dissolve water-insoluable PDLLA, but these solvents 
themselves generally can not be confined to the hydrophilic region. To solve this problem, a 
mixture of water and water-soluble organic solvent with the mixing ratio of water/acetone (or 
W/A) = 50/50 wt/wt is used to etch unwanted PDLLA fibers (optimization of W/A is 
described in the Results and Discussion section). The filling of the etching solution to the 
hydropilic region is realized through microfluidic filling (Fig. 3-2). Placing a droplet of the 
etching solution at the liquid access port of the hydrophilic region with a conventional pipette 
is all that is needed to flow and confine the solution to that region. The microfluidic capillary 
force of the etching solution drives the fluid along the hydrophilic pathway. By placing the 
droplet of the etching solution with a proper volume, adequate filling pressure can be 
achieved to allow driving the fluid through the hydrophilic region. Figure 3-2e shows the 
flowing and confining process of the etching solution on the collector surface.  
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Figure 3-2 Process for modifying the fiber collector surface using the photocleavable SAM 
technology and microfluidic filling of etching solution. (a-b) The OTS hydrophobic SAM is 
formed on the glass surface. (c-d) The hydrophilic regions are patterned under the UV light 
through a photo mask. The gap between the glass surface and the photo mask is filled with 
the NaOH solution. (e) The water-acetone mixture is flowed into the hydrophilic region via 
the microfluidic capillary filling. (f) Fluorescence image of the water-acetone mixture (W/A 
= 50/50 wt/wt) confined to the hydrophilic region. 
Electrospinning of Fibers: The PEO and PDLLA precursor solutions are loaded into 
10 mm-diameter syringes A and B, respectively. A #30 gauge stainless steel needle (Howard 
Electronic Instruments Inc., KS) is electrically connected to a D.C. high voltage supply 
(Gamma High Voltage Research Inc., FL). A syringe pump (model KDS210, Kd Scientific 
Inc., MA) is used to deliver the precursor solution to the needle with a certain distance 
between the needle tip and the collector surface. The electrospinning conditions for PEO are 
in the following: the voltage applied between the spinneret and fiber collector VSC = 6 kV, 
the distance between the spinneret and fiber collector D = 10 cm, and the flow rate of 
precursor solution FR = 0.2 ml/h.  For electrospinning of PDLLA, the following process 
conditions are used: VSC = 9 kV, D = 12 cm, and FR = 0.5 ml/h.  
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Characterization: The diameter of electrospun nanofibers and thickness of fibrous 
mats are characterized using Scanning Electrons Microscope (SEM-JEOL JSM 606LV). 
Samples are sputtered with gold before inspection. The distribution of fiber diameter is 
analyzed by randomly sampling 100 individual fibers. The thickness of electrospun fiber mat 
is measured by tilting the sample stage 45
o
 to get a side view. For each thickness, 10 samples 
were inspected to obtain a statistical value. Fiber diameter and mat thickness are given as the 
mean diameter ± standard deviation. 
3.4 Results and Discussion 
 
The resulting PEO and PDLLA fibers are 500 ± 120 and 930 ± 196 nm in diameters, 
respectively. As expected, the fibers deposited in the hydrophilic regions are dissolved by the 
confined etching solutions. To remove the polymer residues from the hydrophilic surface, the 
surface is gently washed through the careful flowing and withdrawing process of the 
corresponding etching solutions again (DI water for cleaning PEO residue, and a mixture of 
acetone and water with W/A = 50/50 wt/wt for cleaning PDLLA residue).  
Figure 3-3 shows the obtained fibrous patterns using the proposed selective nanofiber 
deposition method. A small amount of fluorescein dye is pre-added to the fiber precursor 
solutions to improve the visualization of the microstructures. Almost all the PEO and 
PDLLA residues are removed from the hydrophilic surfaces because no fluorescence is 
observed from the peripheral regions of the patterns. These patterns have high definition and 
their feature sizes are several tens of micrometers, almost one order higher than those 
obtained using most other methods and comparable to that achieved using the femtosecond 
laser. 
50 
 
 
Figure 3-3  (a) Scanning electron microscope (SEM) image of as-electrospun PDLLA fibers. 
Scale bar represents 10 μm. (b) SEM image of the patterned PDLLA fibrous belt. The inset 
shows the edge of the pattern. (c-f) Fluorescence images of the PDLLA (c, d) and PEO (e, f) 
nanofibrous patterns with various shapes. Scale bars in (b-f) represent 50 μm. 
The selective nanofiber deposition method can incorporate with some nanofiber 
alignment methods to obtain micropatterns in well-aligned nanofibrous mats. We have 
demonstrated the selective deposition of aligned nanofibers by using a pair of electrodes
1
 on 
the microfluidic patterned fiber collector surface. As shown in Figure 3-4, two parallel gold 
electrodes are first formed on the glass slide surface using the conventional microfabrication 
technology [40]. The hydrophobic and hydrophilic regions are then created between these 
two electrodes, followed by the microfluidic filling of the fiber etching solution in the 
hydrophilic region, as described above. Such a spatial configuration results in suitable 
electrostatic forces that stretch the charged polymer jet to span across the gap and align 
perpendicular to the electrodes during electrospinning. Therefore, the aligned nanofibers are 
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deposited selectively in the hydrophobic regions using the same method as that for the non-
woven fibers, expect for using of the paired electrodes. The aligning direction of the 
nanofibers can also be readily adjusted by changing the angle of the parallel electrodes with 
respect to the hydrophobic and hydrophilic patterns (Figure 3-4). These micropatterns with 
high-definition shapes of aligned nanfibers may be used to define the preferred direction of 
cell motion further.  
Due to the inherent porous structure and large surface area of the electrospun mat, the 
confined water-containing etching solution has a fairly high chance to laterally penetrate and 
over-etch the nanofibers selectively deposited in the hydrophobic region. Although the 
obtained patterns always have smaller dimensions than those designed on the photo-mask, 
the amount of the lateral over-etch can be compensated by an increase in the dimensions of 
the pattern designed on the photo mask. Therefore, it is important to identify and understand 
the possible major factors that control the lateral over-etch process. In the following section 
we will discuss the influences of the composition of etching solution, electrospinning 
condition, fiber and mat structure and morphology on the level of the lateral over-etch and 
the pattern definition. 
The introduction of water into proper organic solvent allows confining the mixture to 
the hydrophilic region for patterning water-insoluble fibers, but at the same time decreases 
the etching ability of the mixture. Therefore, a tradeoff exists between the confining property 
and the etching ability of the etching solution. In this study, the former is characterized by the 
contact angle of the mixture on the hydrophilic surface, while the latter is characterized by 
the etching time that refers to the time from completing electrospinning to a visual clearance 
of the PDLLA fibers in the hydrophilic region. Figure 3-5 shows the contact angles θ and the 
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corresponding etching times of water-acetone mixtures with different mixing W / A ratios. 
The θ increases linearly with increasing the W / A ratio. The weak confinement associated 
with the small θ is the possible source of instability under slight perturbations (e.g., the 
impingement of the flying fiber to the etching solution): the etching solution may cross the 
hydrophobic-hydrophilic contact line and then over-etch the fibers in the pattern region. 
Thus, the actual pattern area is reduced significantly (see the image at the upper right corner 
of Figure 3-6). As the θ increases with reducing the acetone content, the etching time 
becomes longer. The optimum W / A ratio and the corresponding θ range from 40 / 60 to 60 / 
40 wt / wt and from 65 to 80 degrees, respectively. Specifically, at W / A = 50 / 50 wt / wt, 
the time for etching the PDLLA fibers is about 17 s, with the lateral over-etch of 3 μm only 
(see the image at the bottom right corner of Figure 3-6). 
 
Figure 3-4 Selective deposition of aligned nanofibers on the collector surface.  The 
hydrophilic and hydrophobic patterns are formed between two microfabricated parallel gold 
electrodes. Scale bars represent 50 μm. 
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The voltage potential VSC, applied between the spinneret and the collector, is another 
important factor to influence the lateral over-etch. As the charged fluid jet moves closer to 
the collector during electrospinning, it achieves acceleration due to the increasing 
electrostatic force. At a high voltage VSC, the impingement force from the flying jet onto the 
etching solution surface could destroy the liquid confinement. Consequently, the etching 
solution may invade into the pattern region, resulting in poor pattern definitions. Figure 3-7 
shows the lateral over-etch of the PDLLA fibrous patterns as a function of the VSC. At VSC = 
20 kV, the lateral over-etch is pronounced. Lowering VSC to 8 kV reduces the over-etch 
effect. 
Both the fiber diameter and mat thickness also affect the lateral over-etch at the edges 
of the fiber patterns. It is observed that in the case of patterning large-diameter fibers, the 
etching solution permeates deeply to the pattern region along the fibers that do not melt 
immediately, causing a severe over-etch of the fibers. The fiber diameter d relies 
significantly on the polymer concentration in the precursor solution. As the PDLLA 
concentration changes from 7.5 to 20 %, d is increased linearly from 500 ± 110 to 1920 ± 
395 nm. The fibers with d = 500 ± 110, 930 ± 196, 1210 ± 258, 1550 ± 320, and 1920 ± 395 
nm are electrospun onto five microfluidic collectors, respectively. The etching solution used 
here has a mixing ratio of W/A = 50/50 wt/wt. The result shows that the lateral over-etch 
increases linearly with the fiber diameter (Figure 3-8). The plausible explanation to the result 
is as follows: i) larger diameters fibers require longer time to melt completely than small 
diameters fibers under the same etching condition, and thus more etching solution penetrates 
into the dry hydrophobic region along the larger diameter fibers, causing more lateral over-
etch; ii) large diameter fibers carry more weight and hit the etching solution harder than 
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small diameter fibers, and hence, interrupting the equilibrium state of the etching solution. 
The resulting vibration of the etching solution will give rise to a large amount of lateral over-
etch. As for the mat thickness, the PDLLA fibrous mats with their thicknesses of 18 ± 4, 30 ± 
7, 44 ± 12, 60 ± 16, 75 ± 19 and 90 ± 23 μm are formed on six microfluidic collectors, 
respectively. They are patterned using the water-acetone mixture (W/A = 50/50 wt/wt). 
Figure 3-9 shows that the amount of the lateral over-etch is also almost linear to the mat 
thickness. It is easy to imagine that the thicker the fiber mat, the larger contact area between 
the mat and etching solution in vertical direction, and thus, the more the etching solution 
violates the deposition region laterally, a higher level of lateral over-etch. 
The selective nanofiber deposition method presented here is fairly simple and the 
minimum requirements are the creation of hydrophilic and hydrophobic regions on the 
collector surface and the confinement of water-containing organic etching solution in the 
hydrophilic region. Besides the PEO and PDLLA, many other nanofibers 
(polymethylmethacrylate, polydimethylsiloxane, polyvinylchloride, polystyrene, and etc) can 
be selectively deposited on glass substrates using this method. Water-miscible polar organic 
solvents (acetonitrile, acetic acid, ethanol, dimethylformamide, ethanol, 2-propanol, and etc) 
are preferred to prepare the aqueous fiber etching solutions; some non-polar organic solvents 
with acceptable SW (dimethylsulfoxide: SW = 25 g / 100 g; tetrahydrofuran: SW = 30 g / 
100 g; 2-butanone: SW = 26 g / 100 g, and etc) can also be used.
31
 Therefore, the wide 
selection of the organic solvents ensures that selective deposition of a broad range of 
nanofibers can be processed on glass substrates with a minor modification to the composition 
of fiber etching solution.  
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Figure 3-5 Dependences of the contact angle of water-acetone mixture (left-axis) and the 
time for etching PDLLA fibers (right axis) on the W/A mixing ratio, respectively. 
 
Figure 3-6 The left and middle columns show the optical images of the water-acetone 
droplets with W/A = 0, 0.2, 0.5 and 1, respectively, placed on the hydrophilic surface formed 
via the photocleavale SAM technology.  The right column shows the lateral over-etch effects 
at the edges of the PDLLA patterns (fiber diameter: 0.93 μm; mat thickness: 30 μm). 
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Figure 3-7 Dependence of the lateral over-etch of the PDLLA pattern on the voltage applied 
at the spinneret.  
 
                   
Figure 3-8 Dependences of the etching time and the lateral over-etch on the PDLLA fiber 
diameter. Error bars, ± s.d. 
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Figure 3-9  Dependences of the etching time and the lateral over-etch on the mat thickness. 
Error bars, ± s.d. 
 
3.5 Conclusion 
 
In conclusion, we have achieved micro-sized, structurally accurate, arbitrary-shaped 
patterns of both random and aligned electrospun nanofibers by etching away unwanted 
nanofibers from the wet hydrophilic region and leaving desired nanofibers in the dry 
hydrophobic region on a microfluidic collector surface. The photocleavable SAM technology 
offers apparent simplicity and flexibility to define the hydrophilic and hydrophobic regions to 
confine water-containing liquid.  Thanks to the microfluidic filling technology, the fiber 
etching solution can be flowed into the hydrophilic region on the collector surface without 
58 
 
using actual microfluidic channels (generally having walls and cover). Considering the 
general difficulties in patterning electrospun fibers that have hindered the fiber’s applications 
in cell biology and tissue engineering, this method reported here could open up some new 
application opportunities by providing arbitrary-shaped, structurally accurate, micro-sized, 
and aligned/random nanofibrous ECM scaffolds.  
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CHAPTER 4. HOLLOW POLYMERIC MICAOCAPSULES 
EMBEDDDING ACTUATORS FOR CONTROLLED RELEASE 
OF ENCAPSULANTS 
4.1 Introduction to Controlled Encapsulation 
 
Controlled encapsulation and release of biological and chemical agents and species 
(e.g., drugs, proteins, vitamins, cells, fragrances, and flavors) is of great importance to many 
applications, ranging from food and pharmaceutical industries to inkless paper [43-46].
 
Particularly, liquid core-polymer shell hollow microcapsules have attracted much attention. 
The polymer shells make microcapsules more stable and robust, not only protecting sensitive 
ingredients against denaturing environments, but allowing for easy handling of liquids [47-
50]. By controlling the thickness, porosity, and/or mechanical strength of the polymer shells, 
it is possible to release the encapsulated ingredient in a controlled manner [51]. From the 
perspective of microcapsule preparations, many methods have been investigated to realize 
different types of hollow polymeric microcapsules such as polymersomes, multilayered 
capsules, and hollow microspheres. The methods include self-assembly of microgels in 
droplets [52], layer-by-layer polyelectrolyte deposition [53], interfacial polymerization [54] 
precipitation by phase separation [55], surface polymerization [56], copolymer vesicles [57], 
multiphase microfluidics [58], and combination of molecular self-assembly and precipitation 
[59]. These methods have led to substantial progress in manufacturing different kinds of 
hollow microcapsules, but have often required relatively non-trivial and complex chemical 
strategies [47]. From the perspective of release mechanisms, presently three major methods 
exist for releasing encapsulated ingredients out of hollow microcapsules [60,61].
 
The first 
method involves shell rupture through applied pressure, where a critical pressure was 
60 
 
determined by the shell material and thickness [62,63]. The second scheme relies on 
dissolving shell material by melting, enzyme attack, or chemical reaction, where molecular 
release over a desired period of time was realized through a slow diffusion process [64-66]. 
The last scheme uses a swellable polymer shell. The mechanical strength of the polymer shell 
could be tuned by external stimuli such as electric fields, pH, temperature, or biochemical 
reaction. This, in turn, changes the diffusion rate of the encapsulated molecules from the 
microcapsules [67-70].
 
Electrospinning is a popular, simple, and versatile technique to generate 
micro/nanofibers from a wealth of materials. It utilizes a high strength electric field to draw a 
charged solution into a liquid jet from a nozzle [71]. Electrospray is similar to 
electrospinning, except that the ejected liquid jet breaks up into small droplets when the 
charged solution has a low viscosity or concentration. New applications of these 
manufacturing techniques are continuously being developed for energy storage, catalysis, 
sensors, and drug delivery, particularly as many interesting complex micro/nanostructures 
(e.g., hollow interiors, core-sheath complexes, and multicompartments [51,72-75]) can be 
realized by using modified electrospinning/spray processes (e.g., coaxial and multijet 
electrospinning/spray). 
We report on the development of a new class of core-shell microcapsules capable of 
regulating the release profile of encapsulated molecules. The uniqueness of the 
microcapsules laid in embedding miniature actuators into their interior (Figures 4-1). The 
embedded actuators were made of electrically-sensitive hydrogel beads that could swell and 
contract by external electric fields. This allowed us to regulate the internal pressure of the 
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liquid core, and thus, the diffusion rate of the encapsulated molecules from the 
microcapsules. 
 
Figure 4-1 Schematic structure and mechanism of the liquid core-polymer shell microcapsule 
for regulated release of encapsulated molecules. The microcapsule contains electrically-
sensitive hydrogel beads in its liquid core. The hydrogel beads expand by external electric 
fields. This causes to increase the internal pressure of the liquid core, regulating the release 
of the encapsulated molecules 
 
Basically, changing the electric field strength applied to the embedded hydrogel beads 
caused redistribution of mobile ions inside the beads. This led to imbalanced osmotic 
pressure, and thus the swelling of the hydrogel beads [76]. 
 
It is believed that the hydrogel 
beads had a positive excess volume: the total volume of the hydrogel beads-solution system 
of the microcapsules increased when more water was imbibed in the hydrogel network [77].
 
The excess volume increased the internal pressure of the microcapsule, thinned the polymer 
shell (and possibly increased its permeability), and thus, regulated the releasing flux of the 
encapsulated molecules. Therefore, the embedded actuators provided an internal control 
variable to a conventional diffusion-based molecule release process, making it possible to 
regulate the release characteristic of the encapsulated molecules from the microcapsules. The 
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microcapsules had the MEMS-like structures and functions [78],
 
and were manufactured by 
the coaxial electrospray or co-electrospray process [79].
 
This technique allowed us to 
integrate the hydrogel beads, form the polymer shell, and load the releasable molecules in a 
single step. 
 
Figure 4-2 Schematic setup of co-electrospray for fabricating the microcapsules embedding 
hydrogel beads.  
 
4.2 Fabrication of Liquid Core-Polymer Shell Microcapsules 
 
Co-electrospray Setup: Figure 4-2 shows the co-electrospray setup for fabricating the 
microcapsules. As a critical component, a coaxial spinneret was formed by inserting a 21-
guage needle into a 23-guage needle (BD Biosciences). The spinneret allowed delivery of the 
inner and outer flows independently by two individual syringe pumps (KDS 2000, Kd 
Scientific). The outer flow contained a polymer solution for forming the shell of the 
microcapsules. The inner flow contained an aqueous solution of hydrogel beads and 
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releasable molecules of interest. A high voltage (Gamma High Voltage Research) was 
applied between the spinneret and a collector. The collector was a grounded conductive 
substrate (a gold-coated glass) 
Polymer Shell and Liquid Core Materials: PDLA solution (solvent: chloroform) was 
used as the outer flow of the co-electrospray process. The hydrophobic property of PDLA 
satisfied a prerequisite for encapsulating aqueous liquids into a polymer shell using co-
electrospray [80-82]. PDLA precursor solutions with different concentrations were prepared 
by mixing PDLA pellets (molecular weight 41000; Lactel Polymers) and chloroform (Sigma-
Aldrich) in appropriate weight ratios.  The solutions were stored at 4 
o
C for 24 h to dissolve 
these pellets and then stirred at room temperature to obtain a transparent, homogeneous 
solution. Deionized (DI) water containing hydrogel beads and releasable molecules were 
used as the inner flow of the co-electrospray process. 10 mg BBG dyes were mixed into 10 
mL DI water and then stirred at room temperature to obtain the BBG solution with the 
concentration of 1 mg/mL. 
Preparation of Electrically Sensitively Hydrogel Beads: There are a lot of different 
hydrogels available sensitive to different external stimuli such as infrared light [83],
 
visible 
light [84],
 
ultrasound [85],
 
temperature [77], and magnetic fields [86].
 
 Here in this work, 
home-made electrically-sensitive hydrogel was used as a model hydrogel. The diameter of 
the hydrogel beads was 3.2 ± 2.1 µm (the mean ± standard deviation obtained from ~200 
hydrogel beads). Different hydrogel bead suspensions were prepared, with the bead 
concentration Cbead ranging from 2 × 10
6
 to 2 × 10
8 
/ mL. The hydrogel precursor solution 
was formed by mixing acrylic acid (Sigma-Aldrich) and 2-hydroxyethyl methacrylate 
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(Sigma-Aldrich) in a molar ratio of 1:4.2, ethylene glycol dimethacrylate (1.2 wt%, Sigma-
Aldrich), and 2, 2-dimethoxy-2-phenyl-acetophenone (1.9 wt%, Sigma-Aldrich). Preparation 
procedures of electrically-sensitive hydrogel beads were described in the following: (a) The 
prepared hydrogel precursor solution was mixed with light mineral oil (NF/FCC, Fisher 
Scientific) in a volume ratio of 1 : 1. (b) The mixture was stirred by a vortex mixer (2000 
rpm; Fisher Scientific) for 20 s and then exposed under ultraviolet (UV) irradiation 
(intensity: 27.5 mW/cm
2
) for 20 s. (c) After the stirring and UV exposure steps in (b) were 
repeated for six times, a mixture of hydrogel beads and mineral oil was obtained. (d) To 
separate the hydrogel beads from the mineral oil, the mixture (3 mL) was added to 2 mL 
methanol (Sigma-Aldrich) in a vial, and then, agitated in an ultrasonic mixer (B2510-MT, 
Branson) for 5 mins. (e) After the resultant mineral oil droplets deposited on the bottom of 
the vial, the mixture of the methanol and hydrogel beads was taken by a pipette and then put 
in a new vial. (f) To separate the methanol from hydrogel beads, the mixture was centrifuged 
in the new vial at 1000 rpm for 5 mins, (g) After the upper methanol was thrown away, 
chloroform (2 mL; Sigma-Aldrich) was added to the vial, to remove the remaining mineral 
oil droplets. (h) After the chloroform evaporated away, methanol (2 mL) was added again to 
re-suspend the hydrogel beads. (i) After the mixture was centrifuged at 1000 rpm for 5 mins, 
the upper methanol was thrown away. (j) The hydrogel beads (diameter: 3.2 ± 2.1 µm) were 
finally obtained after dried in air. 
4.3 Testing of Release Device and Results 
 
The concentration of PDLA polymer solution was first optimized to form 
independent hollow microcapsules by the co-electrospray process. A voltage of Vsc = 9.5 kV 
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was applied between a spinneret and a collector (a gold coated glass cove slip) with a 
distance of Dsc = 10 cm (Figure 4-2). The flow rate or FR for delivering the outer PDLA 
solution and the inner aqueous solution was set to be FRouter = 8 mL/h and FRinner = 0.4 mL/h, 
respectively. As the relative amount of PDLA with respect to the solvent (chloroform) 
decreased, the morphology of the co-electrospray products was found to change from a 
fibrous to spherical form. Figures 4-3 show the continuous core-shell microfibers and 
independent hollow microspheres formed with the critical PDLA-to-chloroform weight ratio 
of WR = 1 : 8 and 1 : 15, respectively. When the WR fell between these two critical ratios, 
the beaded fibrous structures (Figure 4-3) were emerged. When the WR <  1 : 18, the PDLA 
polymer solution was too thin to wrap the inner liquid which flowed out of the spinneret and 
fell onto the collector. Figure 4-4 shows an failure example in which the WR of polymer and 
its solvent is 1:20. This is because when the polymer is further diluted, the surface tension of 
the polymer solution is too low to wrap the inner fluids. 
It was possible to tune the inner diameter ID of the microcapsules by adjusting the 
flow rate of the inner flow FRinner. In this experiment, the WR of the PDLA solution was 
chosen to be 1 : 15. The FRinner was varied from 0.08 to 0.8 mL/hr, while the FRouter was 
fixed at 8 mL/hr. The upper limit of the FRinner was set to be 0.8 mL/hr because above this 
limit, the jetted inner flow separated from the outer flow at the tip of a two-fluid Taylor cone. 
Figures 4-5a-c show that increasing the FRinner (≤ 0.8 mL/hr) had little influence on changing 
the OD (27.35 ± 2.2 µm) of the microcapsules (here, no hydrogel beads were introduced to 
the inner flow of the electrospray process). This was because the change of the FRinner did not 
significantly affect the total flow rate of the two fluids. However, it was obvious that 
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increasing the FRinner gave rise to an increased ID of the microcapsules. Specifically, when 
the FRinner was at 0.08, 0.4, and 0.8 mL/h, the resultant ID was found to be 8.1 ± 2.4 µm, 16.5 
± 3.5 µm, and 19.1 ± 3.8 µm, respectively. In the following sections, each measurement for 
the ID, OD, and shell thickness Tshell of the microcapsules was the mean ± standard deviation 
from ~200 microcapsules (the ID and Tshell were obtained based on their fluorescent images, 
and the OD based on their optical images). 
 
Figure 4-3  Morphological transition of co-electrospray products, obtained by adjusting the 
PDLA-to-chloroform weight ratio or WR from left to right column.Size bar: 10um. 
We investigated controlling the quantity of hydrogel beads inside the microcapsules. 
By mixing a desired concentration of the hydrogel beads into the inner flow of the co-
electrospray process, it was possible to obtain a statistical distribution of the number of the 
hydrogel beads encapsulated within the microcapsules. Basically, the encapsulation of 
hydrogel beads into the microcapsules was a stochastic process following the Poisson 
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distribution function given by the formula ( , ) exp( ) / ( !)
k
f k k    , where f is the probability of 
having k beads in a microcapsule, given an average loading number of λ beads per 
microcapsule [87,88]. Let’s assume that the microcapsules have the ID of 16.5 µm (the 
experimental mean value). Theoretically, when λ = 0.1 (Cbead = 2 × 10
6 
/ mL), 9.05 % of the 
microcapsules have 1 bead and 0.47 % have ≥ 2 beads, whereas 90.48 % contain no beads. 
When λ = 1 (Cbead = 2 × 10
7 / mL), the possibility for a microcapsule to contain 0, 1, and ≥ 2 
beads is 36.79, 36.79, and 26.42 %, respectively. When λ = 10 (Cbead = 2 × 10
8 
/ mL), the 
possibility for one microcapsule to have ≥ 2 beads increases to be more than 99%. Figure 4-6 
shows the fluorescent image of the microcapsules (ID = 16.5 ± 3.5 µm) with embedded 
hydrogel beads (Cbead = 2 × 10
7
 / mL; FRinner = 0.4 mL/hr). Figure 4-7 shows the histogram of 
the number of hydrogel beads observed inside the microcapsules (Cbead = 2 × 10
7
 / mL). The 
statistical distribution of the hydrogel beads in the microcapsules were obtained by counting 
the hydrogel beads in ~500 microcapsules based on their fluorescent images. The 
experimental result was almost in agreement with the theoretical result estimated by the 
Poisson distribution formula.  
 
Figure 4-4 Failure encapsulation example when the WR is 1:20. 
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Figure 4-5 (a-c) Fluorescent images showing the liquid core-polymer shell microcapsules 
without hydrogel beads, fabricated at different inner flow rates: FR = 0.08 mL/h (a), 0.4 
mL/h (b), and 0.8 mL/h (c). The outer flow rate was fixed at 8 mL/h. No hydrogel beads were 
introduced to the inner flow during the electrospray process. The scale bars represent 50 µm. 
(d-f) Histograms of the ratio of the inner to outer diameter (ID / OD) for the corresponding 
microcapsules shown in the same columns above in (a-c).  
 
Figure 4-6 Fluorescence image showing the liquid core-polymer shell microcapsules with 
embedded hydrogel beads. Here, the concentration of the hydrogel beads used the inner flow 
of the electrospray process was Cbead = 2 × 10
7
 / mL. The flow rate of the inner flow was 0.4 
mL/hr. The bright green spots indicate hydrogel beads. The red annular rings indicate the 
PDLA shells.  
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Figure 4-7 Histogram of the number of the hydrogel beads observed inside the microcapsules 
when Cbead = 2 × 10
6
 / mL (left), 2 × 10
7
 / mL (middle), and 2 × 10
8
 / mL (right). 
 
Figure 4-8 (a) Experimental setup for measuring the swelling characteristic of an electrically-
sensitive hydrogel bead. (b) Size responses of two hydrogel beads as a function of an applied 
D.C. voltage. A low voltage was applied and remained on for 5 mins and then off for 5 mins 
before switching to a high voltage application.  (c) Final morphologies of the hydrogel bead 
with the original diameter of 3.26 µm under different voltage conditions. The scale bars 
represent 5 µm. 
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The swelling characteristic of the hydrogel beads was measured by exposing them to 
different electric fields. The hydrogel beads were placed in a 5 mm deep microfluidic 
channel containing DI water with 5 wt% NaCl. The channel was formed between two glass 
slides with conductive indium tin oxide (ITO) coatings. The shape change of the hydrogel 
beads was observed by a phase contrast microscope (DM2500, Leica) (Figure 4-8a). 
Different D.C. voltages (from 0.5 to 10 V with a step of 0.5 V) were applied between the two 
ITO glass slides. Here, a low voltage was applied and remained on for 5 mins, and then, off 
for 5 mins before switching to a high voltage application. 
Figure 4-8c displays the expanded state of a hydrogel bead (original diameter: 3.26 
µm) under different voltage applications. We found that it took ~15 s from a voltage 
application to an obvious expansion of the hydrogel bead, and then, ~18 s for the bead to 
reach a stable size. The response time was found to be independent of the applied voltage. 
This was because the movement of ions and water into and out of the hydrogel was mainly 
determined by diffusion, and the time scales for dimensional change depended on the size of 
the hydrogel structure. Figure 4-8b shows the dimension responses of two different sized 
hydrogel beads (original diameter: 3.26 µm, and 2.15 µm) as a function of an applied 
voltage. The size of the hydrogel bead reached an almost saturation value when the applied 
voltage was greater than 8 V. The data presented in Figure 4-8b was the mean ± standard 
deviation obtained from 10 measurements on each hydrogel bead. 
To demonstrate the controlled release of encapsulated molecules from the 
microcapsules, dye brilliant blue G (BBG, 1 mg/mL) was mixed with DI water containing 1 
wt% NaCl. The NaCl supplement was used to provide enough mobile ions when dissociated 
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in water. A stock hydrogel bead suspension was diluted differently with the BBG-NaCl 
solution to obtain a desired Cbead for the inner flow of the co-electrospray process. To obtain 
enough microcapsules for test, the co-electrospray process was conducted for 2 hrs.  
 
Figure 4-9 (a) Absorbance spectra of BBG molecules released from ten identical samples of 
the microcapsules (ID = 16.5 ± 3.5 µm; Tshell = 5.1 ± 2.8 µm; Cbead = 2 × 10
7 
/ mL) under 
different D.C. voltage conditions. A specific D.C. voltage was applied to a sample. All 
measurements were conducted 2 hrs after the voltage application. The inset shows an electric 
stimulation unit. (b) Cumulative BBG release from the samples measured in (a), as a function 
of the applied D.C. voltage.  
The overall loading efficiency of the BBG molecules into the microcapsules was 
almost 100 % as the BBG solution was directly injected into the inner capillary of the 
spinneret by a syringe pump. The microcapsules were collected by the aforementioned gold-
coated cover slip (1 cm
2
). The collector served as the anode of an electric simulation unit 
shown in the inset of Figure 4-9a. The other gold-coated glass slide (cathode) was placed 5 
mm away from and parallel to the collector. The two electrodes were immersed in a 1 mL 
quartz cuvette (BrandTech Scientific) containing DI water. The cumulative amount of 
molecule release was measured by monitoring absorbance at the characteristic absorption 
wavelength of molecules (for BBG, this is 600 nm) with a spectrometer (2800 UV/VIS, 
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UNICCO). Prior to each measurement, the liquid in the cuvette was stirred gently by a glass 
rod to form a uniform distribution of BBG throughout the cuvette.  
 
Figure 4-10 Transient responses of three identical samples of the microcapsules to different 
D.C. voltages: 0 V (control), 4 V, and 10 V. The black curve is obtained by fitting the 
Higuchi model to the BBG release data of the control sample.  
It was found that as we increased the applied D.C. voltage to the microcapsules (ID = 
16.5 ± 3.5 µm; Tshell = 5.1 ± 2.8 µm; Cbead = 2 × 10
7 
/ mL), the cumulative release of BBG 
molecules from the microcapsules increased (Figures 4-9 a-b). Here, each sample of the 
microcapsules was tested under an applied voltage at a specific value. The upper limit of 
voltage was set to be 10 V to prevent hydrolysis. Figure 4-9a shows the absorbance spectra 
of BBG molecules for different applied voltages, measured 2 hrs after each voltage 
application. The increase in absorbance peak intensity at the wavelength of 600 nm indicated 
that the BBG release increased with increasing applied voltage. Figure 4-9b summarizes and 
plots the BBG release as a function of the applied voltages. Interestingly, when the applied 
voltage was less than 8 V, the BBG release increased almost linearly with the voltage (Figure 
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4-9b). But, at the higher voltages, the increasing rate of the BBG release, with respect to the 
voltage, decreased toward saturation. The explanation to this changing tendency is that the 
swelling of the hydrogel beads approached to an upper limit when exposed to the high 
electric fields as shown in Figure 4-8b. The transient responses of the microcapsules (ID = 
16.5 ± 3.5 µm; Tshell = 5.1 ± 2.8 µm; Cbead = 2 × 10
7 
/ mL) were measured to investigate the 
release kinetics of the microcapsules under different voltage applications (Figure 4-10). 
Three identical samples were tested. Two of the samples were measured by applying the 
D.C. voltage of 4 V and 10 V, respectively, at time t = 0. Another sample served as the 
control sample with no applied voltage, providing the background molecule release from the 
microcapsules. As shown in the control experiment result (the blue dotted plot in Figure 4-
10), the initial release from the sample was detectable by the spectrometer at t = 80 mins 
(representing the diffusion time of BBG molecules through the shell of the microcapsules). 
The cumulative release increased with time, while the increasing rate of release gradually 
decreased. We noted that the release characteristic of the control sample was fitted well by 
the Higuchi diffusion model (Q A t , where Q is the cumulative release, and A is the 
geometrical parameter) [89].
 
In contrast, the application of 4 V caused an earlier initial 
molecule release occurring at t = 72 mins (8 mins earlier than the control sample). As the 
applied voltage increased up to 10 V, the initial release occurred at t = 56 mins, 24 mins 
earlier than the control sample. By comparing the cumulative release of the microcapsules for 
the different applied voltages, we found that in the period of ~40 mins after the initial release, 
the cumulative release rose faster with the high voltage than it did with the low voltage (see 
the slope of each plot). Specifically, at the applied voltage of 0 (control sample), 4, and 10 V, 
the cumulative release was 8.7 ± 1.3, 10.4 ± 1.6, and 13.1 ± 1.7 %, respectively, measured 40 
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mins after their respective initial release (t = 120, 112, and 96 mins). This provided 
quantitative evidence that the embedded hydrogel actuators not only triggered an earlier 
initial release, but enhanced the release rate in a few dozen minutes (~40 mins) after the 
initial release. The higher the voltage applied, the earlier the initial release observed, and the 
more molecules released within that period. This result was consistent with our observation 
in Figure 4-9b that applying a higher voltage increased the volume of the embedded hydrogel 
beads. We note that the regulation of the release profile was effective in a few dozen minutes 
(~40 mins) after the initial release. Afterwards, the molecule release with the applied voltage 
progressed in a similar way to the background release from the control sample (Figure 4-10). 
The explanation of this result is that as some of the encapsulated molecules were released 
from the microcapsules, the elevated internal pressure gradually reduced, and thus, the 
molecule diffusion became a dominating release mechanism. Nevertheless, the result 
demonstrated that the microcapsules were capable of regulating the release profile of the 
encapsulated molecules by changing the internal pressure to influence the regular diffusion-
based release (background release). 
Figures 4-11 demonstrate tuning the release profile of the microcapsules (ID = 16.5 ± 
3.5 µm; Tshell = 5.1 ± 2.8 µm; Cbead = 2 × 10
7 
/ mL) by applying multiple electrical 
stimulations at different time instances. Specifically, the first sample was tested by applying 
identical square voltages (amplitude Vamp1,2,3 = 4 V; duration time tdur1,2,3 = 30 mins) at t = 2, 
3, and 4 hrs, giving rise to the net release of 2.15 ± 0.21, 2.24 ± 0.27, and 2.17 ± 0.24 %, 
respectively (see the three steps on the black dotted plot in Figure 4-4 left). 
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Figure 4-11 Cumulative BBG release from two identical samples of the microcapsules (ID = 
16.5 ± 3.5 µm; Tshell = 5.1 ± 2.8 µm; Cbead = 2 × 10
7 
/ mL), responding to two different 
applied square voltages. The form of the applied square voltages is shown above the release 
profile.  
Thus, the sample released almost equal amounts of BBG under the same voltage 
conditions at different time points and the resulting release profile (the black dotted plot) 
deviated from the background release profile (the blue dotted curve). In the second 
experiment, three different square voltages with increasing amplitude (Vamp1 = 4 V; Vamp2 = 6 
V; Vamp3 = 10 V; tdur1,2,3 =30 mins) were applied to the sample at t = 2, 3, and 4 hrs, resulting 
in the net release of 2.15 ± 0.21, 2.69 ± 0.22, 3.37 ± 0.24 %, respectively (Figure 4-11 right). 
Thus, the higher the amplitude of the voltage, the more the BBG release occurred. To 
demonstrate the possibility of realizing a broad-range tuning of the release profile from the 
background release, we applied ten identical square voltages at different time points to the 
same type of the microcapsules. As shown in Figure 4-12, these square voltages had the same 
amplitude of 10 V and the same time duration of 30 mins. It was observed that each electrical 
stimulation triggered almost the same amount of net molecule release at ~3.4 % (see the ten 
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steps on the plot in Figure 4-11). This allowed us to regulate the release profile of the 
microcapsules with relatively good accuracy. After the ten electrical stimulations, the 
resultant cumulative release was 65.2 ± 2.19 %, while the background cumulative release 
was only 32 ± 1.82 %. Thus, it was possible to realize a wide range regulation of the release 
profile by applying multiple electrical stimulations to the microcapsules. 
 
Figure 4-12 Cumulative BBG release of the sample of the microcapsules (ID = 16.5 ± 3.5 
µm; Tshell = 5.1 ± 2.8 µm; Cbead = 2 × 10
7 
/ mL) under ten identical square voltage 
applications with the amplitude of 10 V and the duration of 30 mins. 
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Figure 4-13 (a) Cumulative BBG release of three different samples. The samples were 
differentiated from each other by the shell thickness of the microcapsules (listed in the plot). 
OD = 27.35 ± 2.2 µm. Cbead = 2 × 10
7 
/ mL. The D.C. voltage of 6 V was applied to the three 
samples at t = 0. (b) Cumulative BBG release of two other samples. They were differentiated 
from each other by the concentration of hydrogel beads used in the outer flow of the co-
electrospray process (given in the plot). The D.C. voltage of 6 V was applied to the two 
samples at t = 0. 
To investigate how the shell thickness Tshell of the microcapsules influenced molecule 
release, three different samples (named sample S1, S2, and S3) were prepared with the shell 
thickness of Tshell-S1 = 3.2 ± 2.1 µm, Tshell-S2 = 5.1 ± 2.8 µm, and Tshell-S3 = 9.1 ± 2.5 µm, 
respectively (note that Tshell-S1 < Tshell-S2 < Tshell-S3). The OD of the microcapsules in these 
samples was the same at 27.35 ± 2.2 µm. The concentration of the hydrogel beads used for 
all three samples was also the same at Cbead = 2 × 10
7 
/mL. The D.C. voltage of 6 V was 
applied to the samples at t = 0. Figure 4-13a demonstrates that decreasing Tshell caused an 
earlier initial release from the microcapsules. Specifically, the initial release time of the 
sample S1, S2, and S3 was found to be tS1 = 40, tS2 = 48, and tS3 = 64 mins, respectively. 
However, it is interesting to point out that after the initial release no obvious difference was 
observed in the cumulative release with time between the three samples. We believe that the 
78 
 
reason is the following: Since the outer diameter of the microcapsules in the three samples 
was the same, their inner diameter had the relationship of IDS1 > IDS2 > IDS3. The volume 
expansion of the hydrogel beads in the different samples was the same under the same 
voltage condition. This caused the internal pressure increase ∆P inside the microcapsules of 
the three samples to have the relationship of ∆PS1 < ∆PS2 < ∆PS3. Thus, the influence of 
decreasing the shell thickness on the release rate of the encapsulated molecules was largely 
counteracted by that of decreasing the internal pressure of the microcapsules. On the other 
hand, to demonstrate controlling the molecule release by changing the quantity of the 
hydrogel beads inside the microcapsules, two other samples (named sample N1 and N2) were 
prepared by using Cbead = 2 × 10
7 
/mL for N1, and 2 × 10
8 
/ mL for N2 (Figure 4-13b). Both of 
the samples had the same Tshell = 5.1 ± 2.8 µm and ID = 16.5 ± 3.5 µm. The D.C. voltage of 6 
V was applied to the samples at t = 0. Because the sample N2 included more hydrogel beads 
than the sample N1, the initial release from N2 (tN2 = 32 mins) was detected earlier than that 
from N1 (tN1 = 48 mins). Over the period of ~40 mins after the initial release, the cumulative 
release from the sample N1 was 10.4 ± 1.51 %, less than that from N2 of 13.34 ± 1.75 %. 
Afterwards, the release curves of the two samples had a similar changing tendency with time. 
Similarly, this was because after that 40-min period, the molecule release in both of the two 
samples was driven only by regular diffusion. 
4.4 Discussions and Conclusions 
 
To elucidate the underlying release mechanism of the present microcapsules, we 
constructed a model of the tri-layer core-shell structure and carried out a numerical 
simulation of the swelling process after a stimulus. According to the experimental result 
79 
 
shown in Figures 4-13b, c, the outer diameter of the microcapsules (ID = 16.5 ± 3.5 µm, Tshell 
= 5.1 ± 2.8 µm, and Cbead = 2 × 10
8 
/mL) increased by 8.5 % as we increased the applied D.C. 
voltage from 0 to 10 V. Thus, the total volume of the hydrogel beads-solution system inside 
of the microcapsules increased as the hydrogel absorbed water. Given the low permeability 
of the PDLA shell, the volume increase was likely caused by the positive excess volume 
when mixing water and polymer in the hydrogel, as has been observed in similar systems.
 
The positive excess volume may be related to voids in the gels or to the different spatial 
arrangement of water molecules in the gels. To account for such an effect, we modified the 
classic Flory-Rehner theory [90, 91],
 
by assuming that each water molecule occupied a 
volume twice as large as the volume it occupies in a pure liquid phase. The static behavior of 
the liquid layer was modeled by an incompressible solid of negligible shear modulus, with its 
volume decreasing as the gel core swelled. The outer PDLA shell was modeled as a neo-
Hookean solid with an elastic modulus 3 orders of magnitude higher than that of the hydrogel 
when dry. 
For illustration purposes, we took the representative values of the experiments and set 
the initial diameter ratio of the gel core, liquid layer, and PDLA shell as 1:2:3.2 as in Figure 
4-14a. Although  in the experiments each microcapsule often contained different numbers of 
hydrogel bead, in the simulation we lumped the volume of multiple beads into one to 
maintain a simple symmetric structure. 
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Figure 4-14 (a) Simulation result of the deformation of a microcapsule before (upper panel) 
and after (lower panel) a stimulus. The color scale in the actuated state indicates the 
distribution of pressure, normalized by the elastic modulus of the polymer shell.  The 
hydrogel bead was removed to show the deformed structure (the pressure in the gel core was 
identical to that in the liquid layer). It was assumed that the volume occupied by each water 
molecule in hydrogel gel was larger than that in liquid water. The swelling of the hydrogel 
bead caused the volume increase of the water-hydrogel system inside, and consequently the 
expansion of the entire microcapsule. (b-c) Optical images showing the increase in the outer 
diameter of the microcapsules (ID = 16.5 ± 3.5 µm, Tshell = 5.1 ± 2.8 µm, and Cbead = 2 × 10
8 
/mL) at three applied D.C. voltages: 0 V (b) and 10 V (c). The scale bars represent 20 µm. 
 
As the actuation mechanism was coupled through a liquid layer, the actual shape and 
number of the gel beads should not affect the overall volume expansion. The gel core was 
initially in equilibrium with the liquid water. To model the effect of the stimulus, we reduced 
the Flory-Huggins parameter from 0.5 to -0.1. Such a change made the hydrogel more 
hydrophilic, so that it would take in more water and swell. The parameters were chosen so 
that the hydrogel beads increased in diameter approximately by a factor of 2 when 
unconstrained, as shown in Figure 4-14. Inside the liquid-filled microcapsule, the bead swells 
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at the expense of the water from the liquid layer. The positive excess volume caused the 
bead-liquid system to expand, resulting in a ~8 % increase in the diameter of the 
microcapsule, and an increased pressure in the liquid layer, as shown by Figure 4-14a  (lower 
panel). The calculated increase of diameter was comparable to that observed in Figures 4-
14b, c. Taking a representative value for the modulus of PDLA, ~2 GPa, we estimated the 
peak internal pressure to be ~600 MPa. For molecules of size ~10
-28
 m
3
, the internal pressure 
provided a chemical potential of ~10 kBT, which was much higher than the entropic driving 
force of regular diffusion and thus dominated the release process. Other than the significantly 
increased driving force, the strain in the shell could also have increased the porosity and 
consequently the permeability of PDLA. However, we believe that compared to the increased 
internal pressure, the permeability change of PDLA was a relatively minor factor (due to the 
~8% increase in outer diameter) in the experiment. To date, it was technically difficult to 
examine the pore size change of the PDLA shells with surrounding liquids. Nevertheless, the 
observed increase in the outer diameter resulted from the increased internal pressure of the 
liquid core, which could dominate the release process of the microcapsules. 
It is known that degradation behaviors of PDLA are generally affected depending on 
the Mw of raw polymers used.
 
Previous research demonstrated that low-Mw (e.g., 17,000) 
PDLA microstructures exhibited a significant degradation and water hydration in the low-
Mw PDLA microstructures, while high-Mw (e.g., 41,000) microstructures showed little 
detectable degradation (until 53 days) [92].
 
Since our microcapsules used the high-Mw 
PDLA (Mw = 41,000) as the shell polymer, we believe that the influence of the polymer 
degradation on the release profile of the encapsulated molecules was negligibly small. 
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There are several issues that remain. The distribution of hydrogel beads inside the 
microcapsules followed the Poisson distribution with a relatively low uniformity. Also, the 
size of our home-made hydrogel beads was not uniform either. To realize a more accurate 
and reliable release system, it is necessary to investigate how to prepare uniform-size 
hydrogel beads and disturb the natural Poisson distribution of the beads inside the 
microcapsules in the future. We note that the incorporation of the hydrogel beads into the 
interior of the microcapsules reduced the actual molecule loading capacity of the 
microcapsules. Also, hydrogel beads may absorb some of the encapsulated molecules. It is 
believed that optimization of the microcapsule dimensions and hydrogel chemistry can 
minimize the loading and release yield issues. However, handling of these issues is out of 
scope of this work. 
We would point out that the present microcapsule scheme with the stimuli-responsive 
hydrogel bead actuators potentially can be relatively generic. By embedding other types of 
hydrogel into this microcapsule structure, it is possible to realize many other microcapsules 
remotely controlled by light,
 
sound
 
temperature,
]
 and magnetic fields.
 
This can provide more 
opportunities for developing controlled release microcapsules that can be interfaced to 
suitable external stimulation sources for delivery of chemical and biological species. 
However, it is important to investigate the workability of the microcapsules under medically 
safe doses of external stimuli that will likely trigger a significant clinical effect. Lastly, the 
internal actuation approach presented in this work potentially could be applied to many other 
existing controlled release mechanisms (e.g. shell rupture, shell dissolving by enzyme attract 
or chemical reaction, stimuli-responsive shell), having a broad impact on controlled 
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encapsulation and release of biological and chemical agents and species (e.g., drugs, proteins, 
vitamins, cells, fragrances, and flavors) that are important to many applications ranging from 
food and pharmaceutical industry to inkless paper. 
We have developed the MEMS-like liquid core-polymer shell microcapsules with 
embedded, electrically-sensitive hydrogel beads. The microcapsules were able to regulate the 
release profile of the encapsulated BBG molecules, by using external electric fields. The 
microcapsules were fabricated using a simple and single-step co-electrospray process. The 
statistical distribution of the number of hydrogel beads embedded in the microcapsules was 
adjusted by changing the concentration of the hydrogel beads in the inner flow of the co-
electrospray process. The inner diameter of the microcapsules increased as the inner flow rate 
increased. We also have demonstrated that the BBG molecule release from the microcapsules 
started earlier for higher applied voltages. Additionally, higher applied voltages triggered the 
release of larger numbers of encapsulated molecules during the first several dozen minutes 
after the initial release. Furthermore, decreasing the shell thickness of the microcapsules 
caused an earlier initial release, while having little influence on the release rate (given that 
the outer diameter of the microcapsules was fixed). Lastly, increasing the number of 
hydrogel beads in the microcapsules resulted in not only an earlier initial release, but a faster 
release during a 40-min period after the initial release. 
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CHAPTER 5. A CONTROLLED BIOCHEMICAL RELEASE 
DEVICE WITH EMBEDDED NANOFLUIDICS CHANNELS 
5.1 Introduction to Controlled Release 
 
Controlled release of active molecules (e.g., drug, gene, DNA, protein, and chemical 
agent) is highly desired for many applications in such diverse fields as pharmaceutical, 
agricultural, cosmetic, and food industries [93,94,95]. Polymeric micro/nanostructures such 
as spheres, tubes, fibers, and membranes play important roles in encapsulating and releasing 
these biomolecules [96-100]. Generally, biomolecules of interest are incorporated in either 
dissolved or dispersed form within a polymer matrix, and then, gradually diffuse out in a 
controlled manner by chemical and biological interactions between the polymer and the body 
environment. This type of controlled release devices often has no complex structures nor 
requires connecting to an external molecule source [96-100].  The other type of release 
devices is formed using micro-electro-mechanical systems (MEMS) technology. They can be 
reloaded with biomolecules of interest and can accurately control molecule release using 
relatively complex MEMS structures [101]. The controlled release device studied in this 
chapter falls in the former category. 
Stimuli-responsive hydrogels are smart materials that can expand and contract, responding to 
environmental stimuli such as glucose, antigen, pH, temperature, light, electric field, and 
ionic strength [102]. Research and development of controlled release devices based on 
stimuli-responsive hydrogels have been attracting much attention [103-110]. However, 
almost all existing hydrogel-based release schemes require chemically incorporating 
eleasable molecules into hydrogel delivery matrices by molecular binding. Liberation of 
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entrapped molecules relies on swelling polymer chains as hydrogels undergo a responsive 
swelling-driven phase transition, or cleaving polymer chains via hydrolytic degradation or 
enzyme attack [106]. Therefore, to realize controlled release of molecules from hydrogels, 
many factors and their interplays have to be taken into account, including polymer-molecule 
binding affinities and interactions, destruction of labile covalent bonds, release kinetics of 
entrapped molecules within hydrogel matrices, and swelling rate of polymer networks 
[107,108]. This may pose complexity and difficulty inndesigning hydrogel pharmacological 
formulations and associated delivery micro/nanocapsules. Electrospinning is a simple, 
effective, and versatile method for producing nanofibers from polymers or polymer blends. It 
utilizes a high electric field to draw a charged polymer solution out of a metallic needle into a 
liquid jet. The jet undergoes thinning, bending, and stretching in air. Finally, nanofibers fall 
onto a collector. Co-electrospinning is a relatively new technology with a coannular nozzle, 
for fabricating complex nanofibers encasing materials such as polymer and liquid crystal 
within a polymer shell. [110,111] New applications of co-electrospun nanofibers are 
expanding. For example, we recently developed flexible light-emitting nanofibers by 
encapsulating liquid metal into a polymer sheath of organic electroluminescent materials 
[112]. 
In this chapter, we report a controlled biochemical release device embedding 
nanofluidic channels into a polymer network of a stimuli-responsive hydrogel (Figure 5-
1(a)). The nanofluidic channels serve as biomolecule reservoirs and are formed by multiple 
liquid core-polymer shell nanofibers. The core layer of the nanofibers contains an aqueous 
solution with biomolecules of interest. The outer layer is made of a hydrophobic polymer 
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shell, functioning as a barrier to minimize lateral leakage of encapsulated biomolecules. The 
nanofibers are fabricated using co-electrospinning and then are embedded into a stimuli-
responsive hydrogel membrane. Two ends of the nanofibers are open. Our hypothesis for 
controlled release of the device is based on buckling instability of the polymer shell of the 
nanofibers. Briefly, interactions between the hydrogel and a specific stimulus cause to 
change physical volume of the hydrogel. As a result, the embedded nanofibers carry a large 
compressive stress in both axial and radial directions, causing buckling of the shell of the 
nanofibers and extrusion of the encapsulated biomolecules. The present device decouples 
releasable biomolecules from a hydrogel polymer matrix, avoiding chemical interactions 
between the biomolecules and the hydrogel polymer chains, and thus, alleviating nontrivial 
chemical and biological engineering design of hydrogel formulations. Therefore, this method 
can make it easier and more accurate to tune and optimize release characteristic of the device. 
5.2 Fabrication of Embedded Nanofluidics Device 
 
To prepare the NIPAAm hydrogel solution, N-isopropyl acrylamide (NIPAAm), 
N,N’-methylenebisacrylamide, dimethyl sulphoxide, deionized water and 2,2-dimethoxy-2-
phenylacetophenone are mixed in the weight ratio of 2.18 : 0.124 : 3.0 : 1.0 : 0.154 and then 
vigorously stirred for 30 mins at room temperature. The PDLA solution is prepared by 
mixing PDLA (i.v. = 0.69) pellets (Lactel Polymers) and chloroform in the weight ratio of 
1:8. This mixture is stored at 4 
o
C for 24 hrs to dissolve these pellets and then vigorously 
stirred for 2 hrs at room temperature to obtain a transparent, homogeneous solution. All 
chemicals are purchased from Sigma-Aldrich unless otherwise stated and used as received 
without further purification. As an important component of the co-electrospinning setup, a 
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coaxial spinneret is formed by inserting a 21-guage needle into a 23-guage needle (BD 
Biosciences). The spinneret allows delivery of the outer PDLA solution and the inner BBG 
solution independently by two individual syringe pumps (KDS 2000, Kd Scientific). The 
voltage of 9.5 kV (Gamma High Voltage Research) is applied to the spinneret. A collector is 
placed 10 cm below the spinneret and formed by patterning two parallel gold (Au) thin strips 
on a glass slide. The flow rate for the core and polymer shell layers is 0.4 and 0.6 mL/hr, 
respectively.  
To embed the nanofibers into the NIPAAm hydrogel, another glass slide is placed 50 
µm above the collector. Then, the hydrogel solution is flowed into the air gap between the 
two slides and then exposed under ultraviolet irradiations. The exposure time and light 
intensity is 12.5 s and 15.3 mW/cm
2
, respectively. After that, the upper glass slide is 
removed. Finally, the hydrogel membrane embedding liquid core-polymer shell nanofibers is 
carefully peeled off from the lower slide and ready for test. 
The device used in this example is structurally identical to that in Figures 5-1a-b. The 
temperature of the device is increased from 22 
o
C at t = 3 hr and stabilized at 28 
o
C after 
~110 s. Then, the temperature is held for 40 s before the heater is turned off. BBG release is 
observed to increase distinctly from ~18.5 to ~28.6 % of the total loading amount (Figure 5-
1a). Similarly, the control “A” device is identical to the actual device, but operates at 22 oC 
(constant). The control “B” device is also identical to the actual device, but has no 
surrounding hydrogel. Figure 5-5b shows the corresponding absorbance spectra of the three 
devices above. 
To demonstrate the mechanism, N-isopropyl acrylamide (NIPAAm) temperature-
sensitive hydrogel is used as a model hydrogel, which expands at low temperatures and 
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shrinks at high temperatures.  Hydrophobic poly (D, L-lactide) (PDLA; PDLA-to-chloroform 
weight ratio¼1:8) and aqueous Brilliant Blue G (BBG, 1mg/ml) solution are used as the 
polymer shell material and inner core liquid, respectively, of the nanofibers. Since interaction 
between water and PDLA is thermodynamically unfavorable, possible lateral leakage of 
BBG molecules through the shell is significantly reduced. Figures 5-1(b)–(d) show the brief 
device fabrication processes for the proposed release device. The fabrication involves using 
co-electrospinning to fabricate BBG liquid core-PDLA polymer shell nanofibers (Figure 5-
1(b)) and using liquid phase photopolymerization to embed the nanofibers into a 50 lm thick 
NIPAAm hydrogel membrane (Figure 5-1(c)). A razor blade is used to cut a strip of the 
nanofiber-hydrogel membrane for testing (Figure 5-1(d)). Here, the BBG solution is 
automatically loaded into the core of the nanofibers during co-electrospinning. The spinning 
time is 1 h, resulting in multiple layers of stacking nanofibers (~45 lm thick in total). The 
nanofibers (liquid core diameter: ~680 nm; PDLA shell thickness: ~145 nm) are aligned 
perpendicular to two gold strip electrodes on a glass slide due to electrostatic interactions 
(Figure 5-1(e)). 
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Figure 5-1 (a) Schematic for structure and mechanism of the controlled release device. 
Fabrication processes for the device: co-electrospinning liquid corepolyme shell nanofibers 
(b); flowing hydrogel solution into nanofiber interstitials and photopolymerization of 
hydrogel (c); cutting a strip of hydrogel membrane embedding nanofibers (d). (e) Fluorescent 
image for part of the fabricated device (green: hydrogel; red: nanofibers). 
5.3 Theoretical Basis for Embedded Nanofluidics Device 
 
We first conduct a theoretical study to elucidate the mechanism. The device is 
regarded as a composite with aligned PDLA nanofibers in a hydrogel matrix. We model 
PDLA as a neo-Hookean material, and NIPAAm hydrogel with the Flory-Rehner model 
[91,115]. The calculation is carried out using SIMULIA Abaqus 6.10 with the hydrogel 
model implemented through a user subroutine [115]. We assume the hydrogel to be in 
equilibrium with pure solvent and execute a static analysis disregarding the drug flow in the 
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core. The Flory-Huggins parameter X is gradually increased from 0.1 to 0.5 to model the 
effect of the temperature-induced phase transformation [116, 117]. The increased 
hydrophobicity causes the hydrogel to shrink. 
For simplicity, we neglect the interaction between nanofibers and only look at a 
single nanofiber in a large piece of hydrogel. The cross-sectional geometry of nanofiber is set 
to that measured, and the elastic modulus of PDLA is set to be 1000 times that of dry 
NIPAAm. The initial water concentration is set to be 97.5 vol. %. The simulated deformation 
pattern is shown in Figure 5-2. During the initial stage of deswelling, the nanofiber deforms 
uniformly (Figures 5-2(a) and (b)). When v further increases beyond a critical value, the 
uniform deformation loses stability, and the nanofibers buckles. The initial buckling is close 
to the Euler buckling of a beam, but as the amplitude increases, the circular cross section 
collapses (Figure 5-2(c)). The cross-sectional images shown in Figures 5-2(d) and 5-2(e) 
clearly illustrate this change. Before the onset of instability, the cross section of the 
nanofibers remains circular, with the diameter slightly increases due to the Poisson effect. As 
a result, the internal volume of the nanofiber is hardly changed, and the liquid drug is not 
released except by diffusion. It is shown that, after buckling, the cross section of the 
nanofiber is flattened, and the internal volume greatly reduced. The drug content is thus 
squeezed out from the nanofiber. Similar to the wrinkles in a hardfilm-soft-substrate system 
[118], the wavelength of buckling is set by the nanofiber geometry and the stiffness ratio 
between the nanofiber and the hydrogel membrane. 
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Figure 5-2 Calculated deformation of nanofiber-hydrogel system at (a) the initial (swollen) 
state, (b) the state before buckling, and (c) the post buckling state. Part of the model has been 
removed to show the fiber. (d) and (e) The cross-sectional view of the fiber at different 
stages. The colorscale shows the axial stress normalized by the modulus of PDLA. 
 
5.4 Measurements of Embedded Nanofluidics Device 
 
As a release indicator, BBG has a characteristic absorption peak at the wavelength of 
600 nm. BBG release from the fabricated device is determined by measuring changes in 
absorption intensity with a spectrometer (2800 UV/VIS, UNICO). A nanofiber-hydrogel 
device is placed on the bottom of a quartz cuvette (BrandTech Scientific) containing 
deionized water. Local temperature of the cuvette is controlled by a Kapton heater, a Type-K 
thermocouple, and a thermostat. Prior to each spectroscopic measurement, the liquid in the 
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cuvette is stirred gently for several seconds using a glass rod, to obtain a uniform distribution 
of BBG molecules within the cuvette. Each measurement cycle takes about 8 s. 
Figures 5-3(a) and 5-3(b) demonstrate temperature response of the device to a 
temperature excitation. Here, the device temperature is increased from room temperature (22 
o
C) at ~1 h and stablized at 26 
o
C after 110 s, and then, it is held for 40 s before the heater is 
turned off (upper panel in Figure 5-3(c)). About 10 s after the temperature stablization, the 
hydrogel starts to shrink and then stops in 10 s. BBG release increases rapidly from 9.1 to 
16.3 wt. % of the total loading amount in 8 s (Figure 5-3(a), and lower panel in Figure 5-
3(c)). To confirm the role of the hydrogel in controlling the molecule release, two control 
experiments (controls “A” and “B”) are conducted. The control “A” device is identical to the 
actual device having both hydrogel and nanofibers, but operates at a constant temperature of 
22
o
C. Thus, molecule release is governed by molecular concentration difference induced 
entropic driving force. It is obvious that the release profile of the actual device deviates from 
that of the control “A” device. We note that increasing temperature can not only trigger 
hydrogel contraction, but also cause to elevate diffusion rate of BBG from the core. It is thus 
necessary to find out how each of the two consequences contributes to regulating the release 
profile of the actual device. The control “B” device only has nanofibers but does not have 
surrounding hydrogel. Under the same temperature activation (upper panel in Fig. 5-3(c)), 
BBG release increases only slightly from 9.1 to 10.6 wt. % of the total loading amount. This 
release counts only a small portion of the total release from the actual device (from 9.1 to 
16.3 wt. %). Response of the device to a different temperature excitation is demonstrated in 
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supplementary material. Therefore, it is confirmed that the hydrogel volume change 
dominates the modulation of the molecule release in the present device. 
We believe that the release action is mainly caused by buckling instability of the 
PDLA shell of the nanofibers. As shown in Figure 5-3(c), almost no BBG molecule is 
released after temperature increases, until a certain delay after which a large amount of drug 
is released. The delay followed by sudden release is an evidence of the buckling mechanism. 
Due to the huge difference in stiffness between the PDLA and the NIPAAm hydrogel, the 
shrinkage of the hydrogel initially would not induce a large deformation in the nanofibers. 
Instead, a hoop stress is developed in the hydrogel surrounding each fiber. With the thickness 
of the shell comparable to its inner radius, the radial collapse of the cylindrical shell may 
seem unlikely if only the hoop stress is present. In this system, the nanofibers also carry a 
large compressive stress in the axial direction, as shown in Figure 5-2(b). The combined axial 
and radial compression is expected to cause the buckling of the PDLA shells. 
Figure 5-4 (left axis) displays net BBG releases from multiple similar devices under 
various temperature excitations. Each nanofiber-hydrogel device is heated up from 22 
o
C (at 
t~1 h) to a specific higher temperature. BBG release is monitored 10 s after a higher 
temperature is stabilized. The result shows that the devices with large temperature rises 
release more BBG than those with small temperature rises. A significant BBG increase 
occurs between 30 and 35 
o
C. A primary reason behind the observation is that the volume 
phase transition point of the NIPAAm hydrogel is around 32 
o
C, near which the hydrogel 
shrinks rapidly. Volume response of the hydrogel membrane embedding the nanofibers is 
shown in Figure 5-4 (right axis). 
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Figure 5-3 Cumulative release profiles (a) and corresponding absorbance spectra (b) of an 
acutal device, and control “A” and “B” devices. (c) A close-up cumulative release profile 
(lower panel) under a temperature excitation (upper panel) starting at t¼1 h over 300 s. 
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Figure 5-4 Net BBG release of different individual release devices as a function of 
temperature (left axis). The starting temperatures for the devices are all at 22 
o
C. The right 
axis shows dimension (width) change of the device shown in Figure 5-2(d), as a function of 
temperature. The highest value of 100% represents no change in hydrogel width at 22 
o
C.  
 
Figure 5-5 Cumulative release from an actual device (red dot) and a control device 
responding to multiple temperature excitations (blue dot). The control device is structurally 
the same as the actual device, except for having no surrounding hydrogel. 
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Figure 5-5 demonstrates real-time regulating the release profile of a nanofiber-
hydrogel device by applying multiple temperature excitations at different time instances. 
Here, the device is excited from 22 to 26 
o
C C at t~1 h, from 22 to 28 
o
C at 2 h, from 22 to 30 
o
C C at 4 h, and from 22 to 32 
o
C C at 6 h, giving rise to release 7.2, 10.5, 15.1, and 10.4 wt. 
%, respectively, of the total loading amount, whereas a control device releases 1.5, 1.9, 2.3, 
and 3.8 wt. %, respectively, under the same conditions. The result not only confirms further 
that the hydrogel functions to squeeze the encapsulated molecules out of the nanofibers, but 
also, more importantly, demonstrates the capability of tuning the release characteristic in a 
real-time manner. 
 
Figure 5-6 Time gap s between observing hydrogel contraction and observing abrupt BBG 
release, as a function of the length of the nanofibers. 
To examine how the length of the nanofibers L affects a time gap s between 
observing hydrogel contraction and observing abrupt molecule release, we fabricate five 
nanofiber-hydrogel devices with different L. As L increases from 6 to 18mm (Figure 5-7), s 
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increases from 8 to 41 s under the same temperature excitation (22 - 26 
o
C at 1 h). Also, the 
increasing rate of s is found to increase with increasing L. A possible explanation is as 
follows. As the nanofibers are being deformed by shrinking hydrogel, the encapsulated 
molecules in the liquid core experience acceleration. When the short nanofibers are used, 
BBG molecules in the deep central region of the liquid core can leave the nanofibers before 
the hydrogel contraction is completed. But, this is not the case when the long nanofibers are 
used: after the hydrogel contraction is completed, BBG molecules have not been away from 
the nanofibers. They continue moving inside the nanofibers mainly by inertia, but not by a 
squeezing force. Due to lack of further acceleration, a longer time is required for the 
encapsulated molecules to leave the nanofibers. 
 
Figure 5-7 (a) Cumulative release profiles and (b) corresponding absorbance spectra of the 
release device, the control “A” device, and the control “B” device. Temperature excitation: 
22 → 28 oC at t = 3 hrs. 
The present work has demonstrated integrating co-electrospun nanofluidic channels 
into stimuli-sensitive hydrogels to realize controlled release of biomolecules. The device 
architecture allows isolating releasable molecules from responsive polymer matrices and, 
thus, minimizing complex chemical and biological engineering design effort of hydrogel 
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formulations. The co-electrospinning process allows for flexible tuning of materials and 
dimensions of the polymer shell and liquid core of nanofibers [110, 111].  Also a wide 
variety of materials (e.g., neural probes, plastic, silicon) may be chosen to collect nanofibers. 
Further elaboration of the controlled release technology is possible by taking the following 
efforts. First, the present device is obtained by cutting from a hydrogel membrane embedding 
core-shell nanofibers. 
To accurately control device dimensions, selective nanofibers patterning techniques 
can be adopted to pattern as-deposited nanofibers [118]. Second, the encapsulated molecules 
in the nanofibers initially diffuse out through the two side openings of the nanofibers. This 
issue could be alleviated by using an appropriate polymer-based molecule carrier in the core 
of the nanofibers. Finally, the simulation result presented here servers the purpose of 
demonstrating the mechanism. With more detailed material models, dynamic release process 
may be simulated. Nevertheless, by employing other specific stimuli-responsive hydrogels 
into the present device architecture, this approach can potentially herald a possible solution 
for controlled release of various biological species and chemical agents. 
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CHAPTER 6. CONCLUSION AND FUTURE WORK 
 
In this thesis, two smart controlled drug release system were developed employing 
electrospinning as the core fabrication technology. The high yield and cost effective property 
of electrospinning facilitate the fabrication of micro and nanofibers as well as spherical core-
shell structures. Both electrospinning products, aligned core-shell fibers and core-shell 
microspheres, are developed and applied in smart biomolecule release systems. 
Environmental sensitive hydrogels are integrated in the two drug delivery systems as the 
sensing and actuation elements. In the MEMS-like liquid core-polymer shell microcapsules 
delivery system, electrically-sensitive hydrogel are fabricated as micron-sized beads. While 
in the embedded nanofluidics delivery device, temperature sensitive hydrogel acts as a bulk 
structure. Both systems are able to control and regulate the release profile of internal 
loadings.  
Electrospinning is the major fabrication technology in this work. Selective deposition 
of electrospun nanofibers using microfluidics confinement method offers a technology 
platform for further applications of electrospinning in biomolecule release systems. A simple, 
versatile method for the selective deposition of nanofibers with high definition using a 
unique microfluidic fiber collector was presented. The collector contains fiber etching 
solutions that are selectively confined to defined regions by means of photocleavable self-
assembled monolayer (SAM) technology and microfluidic capillary filling. The presented 
approach achieves arbitrarily shaped, microsized, structurally accurate architectures in both 
random and aligned nanofibers. Aligned and selected deposited core-shell electrospun fibers 
are successfully applied to fabricate the microfluidics drug reservoir. The electrospinning 
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technology is highly versatile in adjusting the fiber parameters, such as inner and outer 
diameter as well as porosities. These freedoms further provide a method to adjust the loading 
ability and release rate of the system.  
 Core-shell microcapsules are developed capable of regulating the release profile of 
encapsulated molecules. These microcapsules uniquely contain embedded miniature 
actuators inside their liquid core. The internal actuators are made of stimuli-responsive smart 
hydrogel beads. The embedded hydrogel beads swell in response to external electric fields, 
regulating the internal pressure of the liquid core, and thus the diffusion rate, of the 
encapsulated molecules from the microcapsules. The incorporation of the actuators into the 
interior of the microcapsules provides an internal control variable to a conventional 
diffusion-based release process. The microcapsules, which behave much like micro-electro-
mechanical systems (MEMS), are fabricated by a simple co-electrospray process. This 
fabrication technique allows integrating the hydrogel beads, forming the polymer shell, and 
loading the releasable molecules simultaneously in one step.  The microcapsules were able to 
regulate the release profile of the encapsulated BBG molecules, by using external electric 
fields. The statistical distribution of the number of hydrogel beads embedded in the 
microcapsules was adjusted by changing the concentration of the hydrogel beads in the inner 
flow of the co-electrospray process.  
A second controlled release device is developed by embedding nanofluidic 
biomolecule reservoirs into a polymer network of a stimuli-responsive hydrogel. The 
reservoirs are made of liquid core-polymer shell nanofibers using co-electrospinning 
technique. The mechanism of controlled release is based on buckling instability of the 
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polymer shell under combined axial and radial compression, caused by volume changes of 
hydrogel responding to a specific stimulus. The device decouples releasable biomolecules 
from a hydrogel polymer matrix, avoiding chemical interactions between biomolecules and 
hydrogel polymer chains, and thus, alleviating nontrivial chemical and biological engineering 
design of hydrogel formulations. Temperature-sensitive hydrogel is used as a model 
hydrogel. The present work has demonstrated integrating coelectrospun nanofluidic channels 
into stimuli-sensitive hydrogels to realize controlled release of biomolecules. The device 
architecture allows isolating releasable molecules from responsive polymer matrices and, 
thus, minimizing complex chemical and biological engineering design effort of hydrogel 
formulations. The co-electrospinning process allows for flexible tuning of materials and 
dimensions of the polymer shell and liquid core of nanofibers. Also a wide variety of 
materials (e.g., neural probes, plastic, silicon) may be chosen to collect nanofibers. Further 
elaboration of the controlled release technology is possible by taking the following efforts. 
First, the present device is obtained by cutting from a hydrogel membrane embedding core-
shell nanofibers. 
Although we have extensively studied the fabrication process as well as the 
measurement of devices, there are still multiple tasks left to further explore in this area. The 
polymer material we used in this study is mostly a model polymer PDLA. However, the cost 
of PDLA is expensive comparing to other polymers. It would be very promising if a 
substitute polymer could be found to replace PDLA in this system with equal device 
performance to cut down the cost. Finding suitable substitutes will also widen the application 
of this work. 
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A comprehensive theoretical release device model would be necessary to further 
understand the dynamics performance and make comparisons between the above two release 
devices in multi aspects. First, the two devices employ hydrogels in different format: bead 
structure and bulk structure. Although hydrogel performance with respect to its size and 
geometry is studied in other work previously. Hydrogel dynamics and its effect to drug 
release system were not particularly studied. Therefore, a theoretical analysis and 
experimental verification work of hydrogel dynamics at this particular situation will provide 
information on the hydrogel swelling and contracting dynamics, which is the most important 
part of understanding dynamic performance of the drug release system. This theoretical 
model would eventually guide the device design to search for optimum design parameters, 
such as the inner and outer diameters in the fibrous structure and spherical structure, size and 
number of hydrogel beads in each compartment, geometry information regarding the bulk 
temperature sensitive hydrogel. Besides, locating each drug release performance parameter 
with design parameter is highly necessary and desired to accurately define and design release 
systems. 
Electrically sensitive and temperature sensitive hydrogels are used as two model 
hydrogels in this work. Other types of hydrogels are already available, such as photo-
sensitive hydrogel, pressure sensitive hydrogel, pH sensitive hydrogel. Although hydrogel 
materials are bio-compatible, the actual effect of physiological environment to hydrogel and 
to the dynamics performance of the release system is not studied in this work. In the 
microcapsule release systems, hydrogel beads are fabricated in our lab since no commercial 
hydrogel beads in the range of micron are currently available to purchase. Although our 
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hydrogel beads diameter distribution is acceptable to use as preliminary research, a highly 
uniform distributed hydrogel beads with small standard deviation value is necessary to 
accurately study the effect of size and number of hydrogel beads per microcapsule 
statistically. 
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